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Chapter 1: General introduction 
1.1 Introduction  
Herpesviridae is one of the large and extensively diverse families of DNA 
viruses. Due to its huge genomic capacity, herpesviruses encode many genes, which 
are responsible for a variety of biological functions during infection.  Herpesviridae 
is divided into three major subfamilies, Alpha, Beta, and Gamma, on the basis of 
genomic organization, sequence relatedness, and biological properties (16).  
Herpesvirus is able to infect a wide range of hosts and has broad effects on several 
systems including urogenital tract, integument, immune and neurological system and 
so forth. A unique characteristic of herpesvirus infection is life-long latency after 
primary infection. Currently, there are eight human viruses that belong to 
Herpesviridae, HSV-1, HSV-2, VZV, EBV, CMV, HHV-6, HHV-7, and HHV-8 
(107).  
The three major subgroups of herpesviruses cause different pathologic diseases. 
Several of the gamma herpesviruses have cellular transformation and oncogenic 
properties. So far, the genomes of eight gamma herpesviruses have been sequenced 
and their genetic similarity and differences have been analyzed (5).  Rhesus rhadino 
herpesvirus was firstly identified and isolated at New England Primate Research 
center in 1997(19). An outbreak was investigated in the affected monkeys having 
antibody against herpesvirus saimiri (HVS).  A mysterious virus was isolated from 
peripheral blood mononuclear cells of suspected rhesus macaques. Sequence analysis 
of this virus indicated that its sequence and genomic organization were closely related 
to HHV-8. This virus was classified in rhadinovirus subgroup and named rhesus 
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monkey rhadinovirus isolate 26-95 (RRV 26-95) (19).  RRV strain 17577 was 
independently isolated from bone marrow of an SIV-infected monkey with the 
presence of lymphoma (91). Phylogenetic profiling suggested that RRV 26-95 and 
17577 are different isolates of the same virus (2, 90). 
 The long unique region of the RRV genome is approximately 130 kb in length 
and consists of 84 ORFs. The genomic sequence analysis indicated the similarity of 
ORFs to KSHV. Examples are ORF2 (interleukin-6), ORF8 (glycoprotein B), ORF9 
(DNA polymerase), which are closely related to KSHV. Notably, viral interleukin-6 
gene is uniquely present in RRV and KSHV. Not only is RRV’s genome orientation 
entirely collinear with KSHV, RRV genes are also in corresponding locations with 
the same polarity as those in KSHV (2, 19, 90, 91).  
Although RRV infection of peripheral blood mononuclear cells is latent, it 
lytically replicates with high virus titer in rhesus fibroblast cells (RhFs) without any 
chemical induction (19). The kinetics of RRV gene expression in infection are 
characterized into immediate early, early, and late classes. Several genes encoding 
protein homologous to cellular proteins such as vIL-6, are classified as early genes 
(25).    
 Two major hindrances to KSHV study are the lack of an efficient cell culture 
system and an appropriate animal model. Although lytic replication can be 
accomplished by chemical induction, the virus yield is still unsatisfied (87). Several 
groups have been attempting to establish animal models for KSHV; however, there is 
no ideal animal model that develops clinical presentation similarly observed in KSHV 
infection (24, 86, 87). In contrast, virus models have been established. Two bonafide 
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candidates were proposed to study KSHV pathogenesis. They are herpsevirus saimiri 
(HVS) and rhesus rhadinovirus. Whereas the genomic sequence of HVS also has high 
similarity to KSHV, the target cell of HVS is T cells instead of B cells and there is no 
clinical presentation relevant to KSHV infection (50, 53). On the other hand, RRV-
infected rhesus macaques developed lymphoma similar to mulitcentric castleman’s 
disease (MCD) and primary effusion lymphoma (PEL) associated with KSHV 
infection (64). Therefore, RRV has been proposed as a virus model for KSHV 
infection.  
 ORF71 of RRV encodes the viral Fas associated death-domain like interleukin-1 
β converting enzyme (FLICE) inhibitory protein (vFLIP). RRV vFLIP has 
approximately by 40 percent similarity to KSHV vFLIP based on DNA sequence (75, 
91). This gene has also been found in tumorigenic human molluscipoxiviruses and 
gamma herpesviruses, such as KSHV, EHV, and HVS. The vFLIP contains two death 
effector domains commonly shared among several viruses and cellular FLIP (101).  It 
indicates that vFLIP has the ability to inhibit apoptosis. It interrupts the binding 
between caspase-8 and FADD, which prevents the recruitment of death-inducing 
singaling complex. This interruption inhibits the cleavage of procaspase-8 to become 
an active form, caspase-8, eventually blocking the activation of downstream pathways 
of apoptosis (8, 12, 72). The exemplified function of vFLIP has been shown in KSHV 
vFLIP. Besides anti-apoptotic function, it is able to enhance the translocation of NF-
κB from cytoplasm to nucleus (11). This activation of NF-κB causes the up-
regulation of genes involved in apoptosis, cell proliferation, and inflammation that 
participates in tumorigenesis of KSHV (88, 99, 100). A recent study has shown that 
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KSHV vFLIP also suppresses autophagy, also known as type II cell death, by 
preventing Atg3 from binding and processing LC3 (58).  
 KSHV and RRV latent infections have been implicated in malignancies.  Among 
the latent genes are ORF71, 72, and 73. Transcripts of vIL-6 and these three latent 
genes have been detected in lymphoma lesion from rhesus macaque, but the protein 
vFLIP was not detected. The detection of vIL-6 and vFLIP transcripts in the lesion 
from affected rhesus macaque suggested that expression of these two genes associates 
with B cell proliferative diseases and lymphadenopathy (76). In KSHV, the functions 
of viral genes, particularly vFLIP, expressed during latency have been well 
elucidated. Whereas several lines of evidence imply the association of RRV vFLIP in 
malignancy pathogenesis, functional characterization of this protein has not been 
reported to date.  
 
1.2 Research objectives  
Following are the specific objectives of the present study on RRV vFLIP  
 
Objective 1: To determine the function of RRV vFLIP on apoptosis and NF-κB pathways 
  
 












Chapter 2: Literature review 
2.1  Evolutionary and historical perspective of rhesus monkey rhadinovirus  
2.2  Biology of rhesus rhadinovirus  
2.3  Viral FLICE inhibitory protein of rhesus rhadinovirus 
2.4 Apoptosis pathway 
2.5 Autophagy pathway 
2.1 Evolutionary and historical perspective of rhesus monkey rhadinovirus 
 Herpesviruses belong to a large, linear, double-stranded DNA virus family. Most 
of herpesviral genomes contain many ORFs ranging from 70 to 120, with an exception of 
human cytomegalovirus (HCMV), which codes about 220 ORFs.  The genome is 
contained within an icosahedral capsid, which is coated by a proteinaceous matrix and 
then wrapped in a lipid envelope. The members of Herpesviridae have been classified 
into three subfamilies: Alphaherpesviriae, Betaherpesvirinae, and Gammaherpesvirinae. 
Although Herpesviridae composes of a broad range of viruses, their genomes also share 
some conserved genes, such as DNA polymerase and glycoprotein B, across the species. 
The similarity can be determined from amino acid identity comparisons (16, 31, 73).  
There are eight known human herpesviruses.  These include human herpes simplex 1 
(HSV-1), Herpes simplex 2 (HSV-2), varicella-zoster virus (VZV), Epstein-Barr virus 
(EBV), cytomegalovirus (CMV), herpesvirus 6 (HHV-6), herpesvirus 7 (HHV-7), and 
herpesvirus 8 (HHV-8) or Kaposi’s sarcoma associated herpesvirus (KSHV) (107).  
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Several gammaherpesviruses are potentially linked to oncogenic characteristics 
and cell transformation. EBV and KSHV are two bonafide examples involving in the 
pathogenesis of human cancers. EBV is highly associated with Burkitt’s lymphoma, 
Hodgkin’s lymphoma, and nasopharyngeal carcioma, and KSHV is a causative agent of 
Kaposi’s sarcoma, primary effusion lymphoma (PEL), and multicentric Castleman’s 
disease (MCD) (68, 114).  Based on cellular tropism, two groups have been categorized: 
lymphotropism and T-cell tropism. Lymphocryptoviruses (B-cell-tropic) infect great apes 
and Old World primates. T-cell-tropic herpesvirus saimiri of New World primates and 
related members from horses, cattle, and other species are named as rhadinoherpesvirus 
(54).  
In 1997, a herpesvirus related to KSHV was first identified from the colonies of 
rhesus monkey at New England Regional Primate Research Center. Serum samples from 
a large number of rhesus monkeys including healthy and affected animals contained 
antibodies against Saimirriine herpesvirus 2 (Herpesvirus saimiri, HVS). The 
suspiciously related macaque virus was later isolated from peripheral blood mononuclear 
cells cocultured with rhesus monkey fibroblasts. CPE was observed on day 8 to 11 after 
the co-culture. The cells were completely destroyedby day 13 to 16. At low multiplicity 
of infection, foci were found in early destruction of monolayer cells, and became rounded 
and syncitial after infection spread. In addition, intranuclear inclusion bodies were visible 
in the regions where CPE was localized. Electron micrographs indicate that a number of 
viral particles were visible in the nucleus, cytoplasm, and extracellular space. Based on 
genomic organization, sequence relatedness, and predicted amino acid sequence, RRV 
isolate 26-95 was found to be highly closed to KSHV than HVS and any other 
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rhadinoviruses (19). In 1999, the rhesus rhadinovirus 17577 (RRV 17577) was 
independently isolated from bone marrow obtained from an SIV-infected juvenile rhesus 
macaque monkey with a lymophoproliferative disorder (PCD) (91). Its complete genomic 
sequence is greater than 99% identical at the DNA level with the RRV 26-95 isolate. 
From the genomic organization, ORF structure, and phylogenetic analysis similarity, it 
was suggested that the RRV 26-95 and RRV 17577 are different isolates of the same 
virus (90).  
2.2 Biology of rhesus rhadinovirus  
Genome structure and organization 
The first partially sequenced genome of RRV 26-95 was obtained in 1997. 
Column-purified virions without any restriction endonuclease digestion provided DNA of 
more than 25 kbp in length on agarose gel electrophoresis. After digestion with PstI, 
HindIII, and other restriction endonucleases, a broad range of genetic fragments in 
different sizes were observed (19). The complete sequencing of two PstI clones yielded 
10595 bp of partial genome containing the DNA polymerase and glycoprotein B genes. 
Interestingly, the BLAST search analysis of the 10595 bp showed that ORF8 (intact gene 
for glycoprotein B), ORF9 (DNA polymerase), ORF10, 11, and ORF R2 (viral 
interleukin-6) and pertain gene for thymidilate synthetase (TS, ORF70) represented the 
highest levels of similarity to KSHV, herpesvirus saimiri, and other rhadinoviruses (19, 
91).  The predicted amino acid sequences over this region, which contains ORFs 8, 9, 10, 
11 and R2,, were slightly closer to KSHV than other herpesviruses. The selected region 
for sequencing not only provided information related to conserved gene block (DNA 
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polymerase and glycoprotein B genes), but also conferred the variation in nonconserved 
region (R2) among other rhadinoviruses. The new viral genome contains the viral 
interleukin-6 (vIL-6) gene, which is not present in HVS and any other herpesviruses.  TS 
gene promptly comes after vIL-6 in the new virus, while in KSHV, dihydrofolate 
reductase (DHFR) and K3 genes are intercalated between vIL-6 and TS. Although DHFR 
and TS genes have been identified in KSHV and HVS, they are not found in other 
herpesviruses. The location of DHFR and TS genes in HVS genome is different from 
KSHV. Based on these similarities in genome organization and sequences, this new virus 
was classified to the rhadinovirus subgroup and named rhesus monkey rhadinovirus 
(RRV).  In 1999, Robert and his colleagues independently isolated rhesus rhadinovirus 
(RRV) strain 17577 from a simian immunodeficiency virus (SIV)-infected macaque with 
lymphoproliferative disorder (LPD), of which lesion was similarly observed in MCD 
patients. The full length of the viral genome was successfully sequenced and 
characterized. The entire long unique region (LUR) of the genome of an RRV strain 
17577 contains 131364 bp in length and consists of 79 ORFs, of which 67 ORFs 
corresponding to ORFs of KSHV and HVS. In RRV isolate 26-95, its L-DNA has 
130,733 bp that contains 84 ORFs and 83 of them correspond to ORFs in RRV 17577. 
Only one ORF, which belongs to RRV 26-95, but not RRV 17577, contains the sequence 
of herpesvirus core gene ORF 67.5. Although the genome organization of RRV isolate 
26-75 is not entirely co-linear with that of KSHV, in most cases, its genes are in 
corresponding locations and same polarity as KSHV genes (90).    
Some ORFs are uniquely present in KSHV, but not in RRV 26-75. These include 
K3 (bovine herpesvirus-4 immediately-early protein homologous), K7 (nut-1), and K12 
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(kaposin). The sequence differences between KSHV and RRV suggest that these KSHV-
specific genes were acquired subsequent to the divergence of Asian and African Old 
World primates (73). Some sets of genes are partially shared between KSHV and RRV. 
For example, RRV 26-95 contains only one vMIP-1 homologue, while KSHV has three, 
and RRV 26-95 contains eight homologues of vIRF, while KSHV has four.. In addition, 
an ORF encoding 102-aa polypeptide was found in RRV genome and corresponds in 
location to K4.1, K4.2, K5, K6, and K7 of KSHV.  In conclusion, RRV26-95 is closely 
related to KSHV in sequence and genome organization (90).   
       
 
Figure 1. Schematic comparison of selected open reading frames in three gamma 
herpesviruses: RRV, KSHV, and HVS. (19) 
Viral attachment and entry  
Herpesviruses employ the engagement of multiple receptors to infect a broad 
range of hosts. The binding of host receptors by viral glycoproteins is the first step for 
viral entry. Viral DNA is encapsidated in icosahedral structure, which is coated with a 
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layer of protein called the tegument. The outside surface is enveloped with viral proteins 
and glycoproteins incorporated in a lipid bilayer. It has been well studied that 
glycoproteins are greatly essential for the virus entry. Several glycoproteins on virion 
envelope have been identified in the herpesvirus family such as glycoprotein gB, gC, gD, 
gH, gL, gp42, gp350, HHV-8 K8.1A, and so forth. At least three glycoproteins have been 
suggested to participate in the entry of all herpesviruses including glycoprotein B, 
glycoprotein H, and glycoprotein L. The genes of these glycoproteins are conserved 
among herpesvirus family.  The highest degree of similarity is exhibited in glycoprotein 
B. The glycoprotein B can be either homodimer or herterodimer with gH and gL to form 
a prominent spike (97).  
Most herpesviruses gain entry into cells through the initial interaction with the 
cell surface glycosaminoglycans, usually heparin sulfate, but a notable exception is EBV 
(94). So far, three classes of herpesvirus entry receptors have been described. These 
include herpesvirus entry mediator (HVEM, a member of the tumor necrosis factor 
receptor family); nectin (a member of the immunoglobulin superfamily); and 3-O-
sulfotransferases (an enzyme to catalyze the transfer of sulfate to heparin sulfate) (96). 
Different viral glycoproteins have the ability to bind different types of host receptors. For 
example, herpesvirus gC and HHV-8 K8.1A are able to specifically bind heparin sulfate 
and EBV gp350 targets CD21 (B cell receptor), while HSV gD is able to interact with 
several cell surface receptors including HVEM, nectins, and 3-O-sufated heparan sulfate 
(37, 40, 93). The fusion of viral envelope with the plasma membrane of host cells is an 
important step for successful infection. An experiment investigating the viral entry by 
using CHO cells showed that the cells expressing the HSV glycoproteins including gB, 
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gD, gH and gL were able to fuse with other CHO cells expressing cellular receptors. The 
fusion of cells was determined by quantifying expression of a reporter gene activated 
only in heterokaryons. The underlying mechanisms on how HSV gD interacts with host 
cell receptors and facilitates viral entry or cell fusion remain unclear. However, it has 
been suggested that the conformational change during the binding of gD to one of its 
receptors enable the interaction between gD and gB or gH-L to enhance fusion activity 
(70). Most herpesviruses gain entry into a cell by either plasma membrane fusion or 
endocytosis. Plasma membrane fusion is a simple pathway, in which optimal pH between 
cell membrane and viral envelope is not essential for gaining entry (84). In endocytosis 
pathway, however, low pH at the fusion between the membrane of internalized vesicle 
and viral envelop is very critical in facilitating the release of viral nucleocapsid into 
cytoplasm. Then, the viral genome will be delivered into the nucleus through 
nucleocapsid trafficking (95).   
Based on the nature and size of cargo in endocytosis, the entry has been classified 
into clathrin-mediated endocytosis, caveola-mediated endocytosis, clathrin- and caveola-
independent endocytosis, and macropinocytosis (71). The most commonly observed 
uptake pathway for viruses is the clathrin-mediated pathway. Clathrin-coated subunits 
have to detach from the surface of clathrin-coated vesicles containing virus before it fuses 
with early endosome. The viral particle then fuses with endosome and delivers its capsid 
to cytosol. Several observations showed that KSHV, RRV, and other herpesviruses utilize 




Cell types supporting RRV replication 
RRV infects a broad range of cell types. In natural infection, the virus can be 
found in peripheral blood mononuclear cells (PBMCs). B lymphocytes, a subset of 
PBMCs, have been shown to harbor RRV in latency phase (7).  The study of molecular 
virology regarding viral entry, gene expression, and DNA replication requires cell lines 
that support efficient replication of virus. Although RRV latently infects PBMCs in 
rhesus macaques, it is able to lytically replicate in fibroblast cells. In a previous study, 
rhesus monkey fibroblast cells derived from skin punch biopsy were first described to 
coculture with PBMCs from a monkey infected with RRV (19). Several efforts were 
made to increase the lifespan of primary cell lines due to the limitation of a maximum 
passage of 38 for wild type rhesus fibroblasts. An early strategy was to introduce 
oncogenes E6 and E7 of human papilloma virus (HPV) in order to establish immortalized 
primary cell lines (14). However, the two proteins introduced to cells  interfere with 
cellular process by degrading p53 and retinoblastoma tumor suppressor protein (pRb) 
(106). Thus, it is difficult to evaluate the effect of viral gene expression on cell cycle, or 
cell signaling. In addition, phenotypic changes and aberrations in growth characteristics 
are observed as well. Another strategy is to introduce the gene encoding telomerase, an 
enzyme that elongates telomere, into the cells. To establish an immortalized cell line that 
supports RRV infection, Krichchoff and colleagues employed a recombinant retrovirus 
technology to introduce the gene encoding catalytic subunit of telomerase (hTERT) into 
rhesus fibroblast cells (Telo-RhF) (46). These cells can be used for the study of viral gene 
expression, lytic replication, and transcription mapping. This cell line provides the similar 
growth pattern as normal RhFs and telomerase does not affect viral replication. 
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Viral gene transcription and expression 
The hallmark of virus life cycle commonly shared among the herpesvirus family 
is the establishment of lytic and latent infection.  
Unlike KSHV and EBV, RRV can efficiently replicate without any chemical 
induction in permissive cell lines like rhesus fibroblast (RhFs). The kinetic of gene 
expression in RRV following the de novo infection of rhesus fibroblasts was classified 
into immediate early, early, and late class (25). In immediate-early class, RRV ORF50 
gene was transcribed between 6 and 12 h post-infection (hpi). The transcript of ORF50 
gene (approximately 4 to 5 kb) is spliced into two new transcripts. These transcripts were 
named R8 and R8.1 due to homology to KSHV K8 and K8.1 respectively.  However, the 
transcription of ORF50 is sensitive to cycloheximide (an inhibitor of protein synthesis) 
treatment, while phosphonoacetic acid (PAA, an inhibitor of DNA polymerase) fails to 
inhibit its expression. ORF57 is an immediate-early gene that has been described as post-
transcriptional regulator. Its function has been suggested to be responsible for an increase 
of ORF50 transcription at an early time point. It was first detected at 6 hpi before the 
presence of RRV ORF50 and not inhibited by cycloheximide. It suggests that ORF57 
reactivates the viral lytic cycle in conjunction with ORF50 or the ORF50 expression is 
undetectable at early time point due to its low abundance. In early class, R1 gene first 
appeared between 12 to 24 hpi. Its roles in lymphocyte signaling and cell transformation 
were characterized (21). Several of early class genes encode proteins homologous to 
cellular proteins, such as vIL-6. The activity of RRV vIL-6 has been demonstrated in cell 
culture system, and is most likely to have the same characteristic as KSHV vIL-6. The 
initiation of RRV vIL-6 gene expression is detected between 12 and 24 hpi. Inhibition of 
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vIL-6 gene expression caused by cycloheximide was observed at 12 and 20 hpi, while 
PAA did not affect its expression. Latency-associated nuclear antigen (LANA) is 
encoded by ORF73 that is present in both KSHV and RRV. Functions of KSHV LANA 
have been well elucidated, while RRV LANA remains unclear. LANA has a number of 
functions in the viral life cycle, including establishing latency in KSHV infection by 
tethering viral episome to chromosome during cell division. In RRV, however, LANA 
gene transcription was sensitive to cyctoheximide and PAA. In addition, vFLIP and 
vCyclin genes, classified as latent genes, had very similar patterns to that observed in 
KSHV vFLIP and vCyclin genes. It might be possible that ORF71, 72, and 73 have a 
bicistronic or tricistronic transcription pattern. The transcripts of vCyclin and vFLIP 
genes first appeared at 12 hpi and were sensitive to cycloheximide, but sensitive to PAA 
treatment at 30, 36, and 40 hpi. The upregulation feature of latent gene transcripts 
including RRV LANA, vFLIP and vCyclin during de novo infection of rhesus fibroblasts 
was different from the kinetic of gene expression in B cells latently infected with KSHV.  
In late class transcripts, ORF62 was first detected at 24 hpi. Its transcription was 
abolished to PAA and cycloheximide treatment at 12 hpi.  The function of ORF62 
product in RRV is unknown. However, based on homology to other herpesviruses, it was 
implied to play a role in viral assembly and DNA maturation.  Recently, crystal structure 
of KSHV ORF62 product suggested that it is a member of triplex in viral capsid. In 
addition, RRV vIRF and gB genes, encoding viral interferon regulatory factors and viral 





Rhesus rhadinovirus: pathogenesis and animal model system for KSHV  
 A major hindrance for KSHV study is the lack of an in vitro system for 
elucidation of its lytic replication. Although KSHV can infect a wide variety of primary 
cells and cell lines to a certain degree, none of them supports the replication of virus for 
high titer production. While chemical reagents like phorphol ester are used to induce lytic 
replication in vitro, their application for in vivo setting is limited (87). Many in vitro 
experiments and transgenic animal models have been developed to elucidate the 
pathogenesis of KSHV infection.  Recently, Dittmer and colleagues employed SCID-
human Thy/Live mice reconstituted with the liver and thymus of human fetuses to 
investigate the viral transcription and susceptibility of the mice to infection with KSHV 
derived from BCBL-1 cells (86). Furthermore, NOD/SCID mice were utilized to study 
lytic and latent viral gene expression and cell tropism (77). Whereas the previous studies 
have demonstrated the KSHV infection of transgenic mice, none of these models is able 
to elucidate the cellular activation in KSHV-associated diseases and virus-host 
interactions in latent infection. More recently, Chang and colleagues have demonstrated 
that KSHV infects a New World primate, common marmosets (Callithrix jacchus, Cj). 
They have shown that rapid seroconversion and high antibody responses for over one and 
a half years were observed in common marmosets intravenously inoculated with 
recombinant KSHV. Furthermore, KSHV DNA and LANA protein were present in 
PBMCs and tissues of infected marmosets. Surprisingly, two marmosets orally infected 
with rKSHV.219 developed a KS-like lesion with characteristic spindle cells along with 
small blood vessel and extravasated erythrocytes, which were similar to human KS lesion 
in histopathological features. However, the prevalence of LANA-positive staining in KS-
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like lesion in the marmosets was not as strong or widespread as those of human KS 
lesions. In addition, only two KSHV-infected marmosets developed KS-like lesions, 
which were not statistically significant for a conclusion of KS-like lesion development 
after KSHV infection (10).  
 Several groups have been exploring related viruses as models for KSHV. Two examples 
of this model are HVS and RRV, which have genomic organization and sequences 
closely related to KSHV. In New World primates infected by HVS, animals develop an 
aggressive, fulminant lymphoma, which is related to MCD and PEL. But the target cells 
are T lymphocytes instead of B lymphocytes found in KSHV and RRV infection (50, 53, 
54). An early study showed that SIV-infected rhesus macaques inoculated with RRV 
developed B-cell LPD. Two clinical presentations including persistent angiofollicular 
lymphadenophaty, closely relate to MCD and hypergammagloubulinemia that are usually 
observed in AIDS patients coinfected with KSHV.  A recent paper reported that rhesus 
macaques coinfected with SIV and RRV had B cell hyperplasia. However, abnormal 
cellular proliferation as B-cell lymphoma and a proliferative mesenchymal lesion was 
observed at a low percentage of these animals (112). More recently, Orzechowska and 
colleagues (76) reported the involvement of RRV in non-Hodgkin’s lymphoma--a diverse 
group of blood cancers that include all kinds of lymphomas except Hodgkin’s lymphoma. 
Rhesus macaques were intravenously infected with SIVmac239 to induce 
immunodeficient condition, and at 8 weeks after SIV infection, inoculated with RRV 
17577. The monkeys developed latent and persistent RRV infection, lymphoma and 
retroperitoneal fibromatosis. Analysis of viral gene expression associated with the 
development of lymphomas was performed.  The transcripts encoding RRV ORF-R2 
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(vIL-6) and ORF71 (vFLIP) were detected, which is consistent to a previous report on 
vIL-6 in KSHV-infected PEL cells (110). Whereas RRV infection in rhesus macaques 
presents clinical features similar to KSHV-associated MCD and PEL, no evidence of 
clinical presentations similar to Kaposi’s sarcoma has beenfound. Therefore, an 
alternative model to study the pathogenesis and disease progression of Kaposi’s sarcoma 
still needs to be developed.  
Epidemiology 
To detect antibody against RRV, an ELISA test was developed by coating the 
plate with purified RRV 26-95 virions. The prevalence of RRV infection was tested from 
serum samples of 56 randomly selected rhesus macaques, which were from specific-
pathogen-free (SPF) colonies at the New England Regional Primate Research Center 
(NERPRC). Fifty-two of the 56 SPF monkeys (92.8%) were strongly positive for the 
presence of antibody against RRV strain 26-95. In addition, serum samples of many 
monkeys from a conventional colony at NERPRC also had highly reactive antibodies 
against this virus. The high rate of antibody detection suggested a high prevalence of 
RRV infection in the colony. Interestingly, serum samples taken from rhesus monkeys at 
NERPRC in 1985 and stored frozen also showed a high rate of strong antibody reaction. 
In addition, serum samples from rhesus monkeys at two other institutions were also 
tested. All of forty serum samples from one primate facility and a commercial supplier 
showed strong antibody reaction against RRV. Several lines of evidence demonstrated 
that rhesus monkeys were naturally infected with a herpesvirus in the rhadinovirus 
subgroup. The route of natural infection remains unclear, but evidence from KSHV and 
observation from high rate of seropositivity implied that the oral route may be a major 
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route of transmission. It was reported that close contact might be required for infection by 
other gamma herpesviruses (15, 19).              
Diagnosis 
Many diagnostic tools are available to investigate RRV infection. One of the most 
sensitive and less time-consuming methods is to detect the presence of antibody in serum. 
Whole-virus ELISA was developed and used to determine RRV serological status of 
monkeys in a colony (19). Serum samples from monkeys 4 to 7 months after birth were 
negative for the presence of antibody. However, subsequent serum samples from these 
monkeys after 1 year became strongly positive.  
Viral isolation and PCR are also employed for RRV diagnosis. Viruses isolated 
from peripheral blood mononuclear cells are able to infect primary fibroblast cells and 
cause efficiently lytic infection. High viral yield can be further determined with other 
methods. In addition, plasma, whole blood, and other biological specimens are the source 
for DNA isolation and amplification by using PCR. Although detection of nucleic acid 
with PCR can  provide beneficial information for diagnosis, it requires caution to 
interpret negative results due to less sensitivity than serological assays (64).   
2.3 Viral FLICE inhibitory protein 
 vFLIP in human molluscipoxviruses and several herpesviruses including KSHV, 
EHV-2, and HVS was found to inhibit apoptosis induced by death receptors (101). 
Interaction between extracellular death stimuli and death receptors causes the recruitment 
of the adapter molecule Fas-associated death domain (FADD), which interacts with 
procaspase-8 to form a complex, known as the death-inducing signaling complex (DISC). 
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The DISC formation allows procaspase-8 to be cleaved into its active caspase-8 and 
subsequently activates other downstream effector caspases, leading to apoptosis. The 
recruitment of DISC relies on interaction between death effector domains that present in 
adaptor protein like FADD and N-terminus of procaspase-8 (12, 72).  Several viruses 
targeting apoptosis pathway employ different strategies to block Fas and tumor necrosis 
factor receptor (TNFR) signaling. For example, the E3-10.4 protein of adenovirus is able 
to degrade Fas (23). M-T2 protein secreted from myxoma virus can bind to TNF and 
interfere with its binding to TNFR. Four different proteins (crmB, C, D, and E) encoded 
by cowpox virus are able to inhibit TNF activity.  Some viruses suppress apoptosis by 
inhibiting the activity of caspases. Adenovirus 17.4 protein and crm A inhibit activity of 
caspase-8 and inhibitor of apoptosis protein (IAP) (39).  Many of gamma herpesviruses 
employ vFLIP to interfere with interaction between caspase-8 and FADD. vFLIP 
contains two death effector domains (DEDs) that has been shown to bind to DEDs of 
FADD and capase-8. In addition, EHV-2 E8 gene encoding a DED-containing protein 
was demonstrated to block the recruitment of DISC (6). Raji B cells expressing vFLIP 
are resistant to apoptosis (36). Furthermore, the other receptors that belong to death 
receptor subfamily or TNFR such as TNFR-related apoptosis mediating protein 
(TRAMP) and TNF-related apoptosis-inducing ligand (TRAIL) were also blocked by 
coexpression of vFLIP. Similarly, Cellular FLIP or cFLIP also is also involved in the 
inhibition of apoptosis pathway via the activation of several death receptors including 





Structure and function of two death effector domains of vFLIP  
 The structure of vFLIP consists of six antiparallel -helices, which are commonly 
shared by caspase recruitment domain (CARD). Although two DEDs were similarly 
observed in FADD, vFLIP, cFLIP, and caspase-8, different residues in DEDs make their 
individual structures unique (33). Whereas DED-containing proteins have been known to 
inhibit apoptosis, the underlying mechanisms are still unclear. The structure of the 
tandem DEDs of MC159 was first crystallized(61). The full-length protein consists of 
two tandem DEDs and a C-terminal extension.  DED1 and DED2 are bridged by a stretch 
of 14 amino acids, which form a short helix α7 and two surface loops.  Both structure and 
sequence anaylsis suggested that the interaction at the DED1 and DED2 interface are 
highly conserved among all proteins that contain tandem DED domains. This conserved 
rigid structure and interface between the tandem DEDs can be an ideal model of vFLIPs, 
c-FLIP, caspase-8, and caspase-10. Although there is no sequence homology between 
DEDs of MC159 and CARD domains of apoptotic protease activating factor 1 (Apaf) and 
caspase-9, the interaction between two DEDs is similar to that between the CARD 
domains (82). The interaction between caspase-8 and vFLIP are thought to antagonize 
apoptosis. MC159 employs two conserved surface binding elements to interact with the 
DEDs of caspasea-8.  
vFLIP was encoded by several viruses including KSHV, RRV, HVS, EHV, 
bovine herpesvirus (BHV), molluscum contagiosum virus (MCV), and Sindbis virus 
(SV), (101). Although they share common structure, vFLIPs from different viruses 
function differently. Functional characterization of KSHV vFLIP has been more 
extensively investigated than the other herpesviruses. KSHV vFLIP inhibits caspase-8 
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acitvation. Comparative proteome analysis showed that manganese superoxide dismutase 
(MnSOD), a mitochondrial antioxidant and an important antiapoptotic enzyme, was 
dramatically upregulated in endothelial cells expressing KSHV vFLIP (103).  A unique 
feature of KSHV vFLIP distinct from other vFLIPs is that it constitutively activates NF-
κB pathway through enhancing the degradation of IκB, which allow RelA/p65 subunits to 
translocate into the nucleus and activate gene transcriptions (11, 30). The activation of 
NF-κB pathway is very important in at least two aspects: maintenance of latent infection 
and transformation. NF-κB activation can greatly suppress the AP-1 pathway, which is 
essential for lytic replication. In terms of oncogenesis, KSHV vFLIP can transform Rat-1 
cells by activation of NK-κB signaling. This finding was substantiated by observation of 
tumor development in nude mice injected with Rat-1 cells expressing KSHV vFLIP 
(100).  Furthermore, NF-κB activation is able to prevent anoikis, a type of programmed 
cell death in anchorage-dependent cells detaching from the surrounding extracellular 
matrix. It was suggested that anoikis is inhibited by vFLIP through inducing the secretion 
of some paracrine survival factors. vFLIP inhibition, however, does not protect cells from 
apoptosis induced by the removal of essential survival factors, including vascular 
endothelial growth factor (VEGF) (26).  Recently, Lee and colleagues (58) found another 
role of KSHV vFLIP on autophagy, a type II programmed cell death with accumulation 
of autophagosomes. The viral and cellular FLIPs suppress rapamycin-induced autophagic 
cell death by preventing Atg3, a protein enhancing autophagosome formation, from 






Like other gamma herpesviruses, RRV also encodes vFLIP. Based upon the 
primary DNA sequence of RRV 26-95, ORF71, which encodes vFLIP, has 40.1% and 
99.4% similarity to KSHV and RRV isolate 17577, respectively (75). RRV vFLIP is also 
expressed during latency period as observed in other herpesviruses.  Although RRV has 
been proposed to be a model to study the KSHV pathogenesis, the functions of several 
latent genes such as LANA, vCyclin, and vFLIP are still unclear. However, an 
experiment in rhesus macaques suggested that vIL-6 and vFLIP involve in the RRV 
pathogenesis in B cell hyperplasia and persistent angiofollicular lymphadenopathy, which 
resembles to MCD associated with KSHV (110). Transcripts of RRV ORF-R2 and 
ORF71, which encodes vIL-6 and vFLIP, respectively, were detected in the lymphoma 
tissues from rhesus monkeys coinfected with RRV and SIV. So far, functional 
characterization of RRV vFLIP has not been reported.  
2.4 Apoptosis pathway 
Apoptosis, a programmed cell death, plays a key role in multicellular organism to 
get rid of unwanted cells. The term “apoptosis” was coined by Currie and colleagues in 
1972 to characterize a common type of programmed cell death in various cell types. 
Under microscopic observation, these dying cells shared the morphologic changes, which 
were different from the features in necrotic cell death. It was suggested that these features 
might result from the underlying conserved biochemical events. During early apoptosis, 
most organelles in the cytoplasm, except mitochondria and Golgi apparatus, are packed 
tightly and chromatin in the nucleus starts condensing irreversibly. In the late state, the 
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entire cell is associated with cell shrinkage and membrane blebbing in order to reorganize 
a number of small seal membranes that are often referred to as “apoptotic bodies”. The 
size of these membrane-bound vesicles can vary from 0.5 to 2 µM.  They also contain the 
various combinations such as part of condensed nuclei or organelles and cytosolic 
elements (45). These bodies are subsequently engulfed and digested by other cells such as 
macrophages and parenchymal cells. In this process, no inflammatory reaction is detected 
due to the following reasons. First, the cells that die via apoptosis do not release any of 
harmful cellular constituents such as hydrolase, protease, and lysozyme into the 
interstitial space. Second, this complicated mechanism does not promote the secretion of 
pro-inflammatory cytokines. Last, the rapid phagocytosis by surrounding cells can 
prevent secondary necrosis (89). The morphological changes during apoptosis get 
involved in highly complicated biochemical events and are energy dependent.  Two 
important players in apoptosis are evolutionarily conserved protein families, namely the 
BCL-2 family of apoptosis regulatory proteins and the Cysteinyl Aspartate-Specific 
proteASE (Caspase).  
BCL-2 (B-cell lymphoma) protein family was discovered in chromosomal 
translocation involvingchromosome 14 to 18 in B-cell follicular lymphoma. It triggers the 
excessive driving of immunoglobulin heavy chain gene promoter and enhancer on 
chromosome 14 (13). BCL-2 plays a role in promoting cell proliferation and inhibiting 
cell death (105). The functions of BCL-2 are essentially diversified in apoptosis, 
development, programmed cell death, tissue turnover, and host defense against pathogens 
(60). So far, at least 12 core BCL-2 family proteins have been identified in mammals. 
These include the BCL-2 itself and the proteins that share the three dimensional structure 
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or predicted secondary structure with BCL-2. The unique feature of BCL-2 protein 
family is that they contain the so called BCL-2 homology domains (BH1, BH2, BH3, and 
BH4). BH3-containing proteins, the most common in the family, are related to promote 
apoptosis through the regulation and interaction with the other core BCL-2 family 
proteins. In mammals, the members of BCL-2 protein family are classified into three 
subfamilies: BCL-2 subfamily (pro-survival), Bax subfamily (pro-apoptotic), BH3 
subfamily (pro-apoptotic). BCL-2 subfamily consists of several members such as BCL-2, 
BCL-XL, BCL-W, MCL1, BCL-B and A1 (44). Their major function is to inhibit 
apoptosis. The deletion of genes in the BCL-2 subfamily leads to arrays of cell defects. 
Knockout BCL-2 gene causes abnormal death of renal epithelial progenitor (29). 
Abnormal death of fetal erythroid progenitor and neurons was promoted by deletion of 
BCL-XL gene (105).  The absence of BCL-W gene resulted in abnormally accelerated 
death of granulocytes and mast cells (80). BCL-2 and BCL-XL have anti-apoptotic 
function via binding and regulating Bax subfamily proteins (BAX and BAK). BAX/BAK 
activation is a critical step to induce cells to undergo apoptosis through inducing 
permeabilization of the outer mitochondrial membrane (OMM) and the subsequent 
release of cytochrome C, which further trigger caspase-9 activation and execution (43). 
The members of BH3 subfamily such as BAD, BIK, BID, BIM, NOXA, and PUMA 
contain a conserved BH3 domain that allows them to interact with anti-apoptotic BCL-2 
proteins to promote apoptosis. The deletion of genes in BH3 subfamily can cause several 
defects. For example, BID-deficient mice are resistant to Fas-acitvation-induced 
hepatocyte killing and fatal hepatitis. Cells with depletion of PUMA gene are resistant to 
DNA damage. Lacking of BAD in some cell types leads to mild resistance to deprivation 
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of epidermal or insulin growth factors. And lacking of BIM leads to abnormal 
accumulation of lymphoid and myeloid cells (98).     
Caspases 
  Caspases are cysteine proteases that can cleave substrates after an aspartate 
residue at sites bearing tetrapeptide motifs. Caspase-1 (interleukin-1β-converting enzyme 
or ICE) was the first identified caspase in humans. In Caenorhabditis elegans, ced-3 gene 
(cell-death abnormality-3) was discovered to encode a cysteine protease closely related to 
the mammalian ICE (116).  At least 14 caspases have been identified in mammals, of 
which 11 have been found in humans. Furthermore, the homologues of caspases have 
been reported in several species, such as Drosophila melanogaster (common fruit fly), 
Spodopteran frugiperla (fall army worm), and Saccaromyces cerevisiae (yeast). The 
crystal structures of caspases including mammalian caspase-1, -2, -3, -7, -8, -9 and 
Spodopteran frugiperla caspase-1 have been well studied (55).  The highly conserved 
caspase monomer consists of two subunits; one large and one small. Homodimerization 
of several monomers leads to the conformational structure of the active site.  Caspase 
activation pathway is commonly conserved among nematodes, fruit flies, and mammals. 
The function of caspases involves several cellular pathways including apoptosis, 
inflammatory response, and necrosis (56). However, at least 7 out of 14 known 
mammalian caspases play key roles in apoptosis. There are two classes of apoptotic 
caspases; initiator and effector. Newly synthesized caspases in cells do not function and 
must be proteolytically activated during apoptosis signaling. Activation of an effector 
caspase requires cleavage by an initiator caspase at specific internal aspartic acid 
residues. In contrast, the initiator caspases can autolytically activate themselves and 
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trigger a cascade of downstream activation. Once effector caspases are activated, the 
proteolytic cleavage of a broad spectrum of cellular targets triggers apoptosis (28).  
Intrinsic pathway  
 The intrinsic pathway requires no extracellular receptor to trigger apoptosis, but 
the intracellular signals take part in apoptosis. The stimuli could act in either negative or 
positive manner depending on interaction of either pro-apoptotic or anti-apoptotic cellular 
proteins. The disruption of mitochondria membrane and the release of cytochrome C into 
cytosol enhance the activity of cytosolic protein called Apaf-1, which recruit procaspase 
9 to assembleapoptosome, a caspase-activating complex.  This results in an activation of 
caspase-9 and initiation of the execution caspase pathway.  
Extrinsic pathway  
Extrinsic pathway is initiated from the interaction between ligands and receptors 
at the transmembrane.  Ligands can be either soluble factors or receptors that are present 
at the surface of the cells such as cytotoxic T lymphocytes (CTL). TNF-family ligands 
exert their biological functions within the immune system, inflammatory responses, and 
apoptosis. Death receptors on cell surface belong to the tumor necrosis factor gene 
superfamily (TNF). The members of TNF receptor family contain the cysteine-rich 
repeats of 40 amino acids at extracelluar amino acid terminal. Some also share the similar 
sequence in cytoplasmic regions, while others contain homologous region in intracellular 
domains known as death domains. The binding of death-inducing ligands and TNF 
superfamily receptor initiates the fusion of lipid raft, which leads to the clustering of 
extracellular death receptors and conformational change in the intracellular domains. A 
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variety of apoptotic proteins are then recruited to form protein complex, Death Inducing 
Signaling Complex (DISC), followed by the activation of caspase-8 and effector caspases 
in the execution pathway.     
Execution pathway 
 Execution pathway is considered as the final part of apoptosis, where intrinsic and 
extrinsic pathways eventually merge at this point.  Caspase-3, -6, and -7 act as effector 
molecules to induce degradation of nuclear materials by activation of cytoplasmic 
endonucleases. Caspase-3 is considered as the most important executioner because it 
receives signal from both extrinsic and intrinsic pathways through caspase-8 and -9, 
respectively.  Finally, caspase-3 enhances the release of caspase-activated 
deoxyribonuclease (CAD) from its inhibitor to degrade chromosomal DNA.   
Perforin/granzyme pathway 
  Perforin and granzyme are granules in cytotoxic T lymphocytes (CTLs). They are 
released after CTLs bind to target cell receptor such as FasL/FasR. During degranulation, 
perforin inserts into the plasma membrane, forms a pore, and allows the granzyme to get 
into the pore. Granzyme, a serine protease, has been characterized into two major types; 
A and B. Granzyme B promotes apoptosis by activating procaspase-10 and cleaving 






2.5 Autophagy  
Autophagy was first introduced at the CIBA Foundation Symposium on 
lysosomes in 1963 by Christian de Duve, who is considered as the founding father of this 
research area (47). The term autophagy (from “auto” oneself, “phagy” to eat) consists of 
multiple-step intracellular process in degradation pathway that involves the delivery of 
cytoplasmic cargo to lysosomes (59). Autophagy showing double-membrane vesicles 
containing organelles and the other contents in cytoplasm was described as its 
characteristic under electron microscope observations (52).  Whereas autophagy is a 
simple and nonspecific process in degradation pathway, recent data have demonstrated 
that it specifically sequesters damaged mitochondria to prevent the release of cytochrome 
C that activates the intrinsic apoptosis pathway (85). Autophagy is a basic mechanism to 
remove damaged organelles and long-lived proteins. Inefficiency of this process is linked 
to human pathophysiological conditions including neurodegenerative disease, muscle 
disease, cancer, immunity, and host pathogen interaction (59). Unlike apoptosis pathway 
extensively has been studied  since the early  1990s, autophagy has emerged in past ten 
years even though it was first introduced approximately 40 years ago (47).  Although this 
has been a rapid increase in the number of autophagy-related publications, our 
understanding of autophagy is limited and many challenging questions are waiting to be 
answered.      
Autophagy is a dynamic and, multi-step process regulated at several steps (48). A 
cell maintains homeostasis at a low basal level of autophagy, but it is rapidly upregulated 
to generate more energy and nutrients during starvation, undergo architectural 
remodeling during differentiation, and remove damaged bulk of cytoplasm during 
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oxidative stress (92). Two major effectors play significant roles as nutrient sensors in 
autophagy modulation. The target of rapamycin (TOR) shuts off autophagy by integrating 
the signals from upstream pathway including insulin, growth factor, and mitogen 
(upstream and downstream of mTOR). The eukaryotic initiation factor 2α (eIF2α) kinase 
Gcn2 and its downstream target Gcn4, a transcriptional tranactivator, turn on autophagy-
related genes (Atgs) during starvation (92). The whole process of autophagy starts with 
the formation of autophagosomes and ends up with lysosomal fusion (74). Approximately 
17 Atg proteins, first described in yeast, are essential in induction, generation, 
maturation, and recycling of autophagosomes (49).  
Autophagy and its cell survival mechanism 
Recent evidence suggests that autophagy is required to maintain cell survival. 
Deltetion of Atg genes results in the loss of cell survival protection during nutrient 
depletion. When nutrient is depleted, cells employ autophagy to convert the source of 
metabolic substrates to maintain  cellular activity (104). Recent studies have shown that 
organisms lacking Atg genes have increased cell death. In C elegan model, silencing of 
Beclin-1 and Atg-7 results in reduction of autophagy in the pharyngeal muscle and 
survival of wild-type worms after nutrient depletion (41). Several studies intended to 
elucidate the function of Atg proteins on survival modulation. Levin and coworkers 
indicated that autophagy genes are implicated in lifespan control (67). Silencing of Atg6 
(BEC-1) with RNAi inhibits the lifespan extension in mutants by reducing DAF-2/IGF-1 
receptor activity. Depletion of Atg-7 and Atg-2 suppresses the long-lived phenotype of 
daf-2/Igf-1 mutant nematodes (34). These results indicated the important role of 
autophagy pathway on promoting longevity. Not only is autophagy able to maintain 
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cellular homeostasis during starvation, but also enhance removal of damaged 
mitochondria, other organelles, and protein aggregation.  These fundamental mechanisms 
are also utilized in various cellular pathways that are critical in rescuing cells during 
aging, neurodegenerative process, and infection (48). Not only normal cells but cancer 
cells also take advantage of autophagy. Under limited blood supply, autophagy may 
provide the source of energy to promote tumor development.  Recent findings 
demonstrate that over-activation of the Ras signaling pathway observed in several types 
of cancers enhances autophagy, allowing solid tumors to survive until vascular support 
can be established (17). However, the function of autophagy to enhance cell survival is a 
self-limited process. The starving cells will eventually commit to die of necrosis due to 
energy depletion.    
Autophagy: another pathway for cell death  
Mutilcellular organisms control their cell numbers by elimination of abnormal 
damaged cells.  Two major types of programmed cell death have been differentiated by 
morphological criteria. Type I cell death or apoptosis is defined by the presence of 
nuclear condensation and fragmentation without major ultrastructural changes in 
organelles, while Type II cell death (autophagy) is characterized by accumulation of 
autophagosomes in the cytoplasm (4). It has been known that a cell can manifest large-
scale autophagy shortly before or during their death, but the underlying mechanisms in 
autophagic cell death are still unclear. In addition, autophagy has been proposed as an 





) with double knockout of Bax and Bak genes have been widely 
used to determine the association between apoptosis and autophagy.  Instead of 
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undergoing apoptosis after exposure to a variety of apoptotic stimuli, cytoplasm of Bax-
/Bak- double knockout cells were filled with numerous double membrane vesicles, which 
have been confirmed to be autophagosomes by the punctate distribution of GFP-LC3 
(108). These results indicated that autophagosome formation was required for certain cell 
death and that there is an alternative death mechanism other than apoptosis pathway. 




 cells committed to death 
accompanied by autophagic vesicles when treated with etoposide (a cancer drug 
inhibiting topoisomerase II) or staurosporine (an antibiotic drug preventing ATP binding 
to the kinase). In addition, silencing of Atg 5 or Beclin 1 was able to relieve the presence 
of autophagosomes and cell death. Consistently, Lenardo and colleagues (115) reported 
that human U937 and mouse L929 cells that were treated with a pancaspase inhibitor 
(zVAD) underwent non-apoptotic cell death with the presence of autophagosomes, which 
is inhibited by RNAi- mediated knockdown of Atg5 and 7. The report showed that 
caspase and apoptosis inhibitor, zVAD, can inhibit autophagy pathway (111).  Dual 
inhibition by zVAD leads cells to die via necrosis because apoptosis and autophagy are 
simultaneously inhibited.  A recent study showed that induction of autophagy by nutrient 
depletion resulted in a significant protection against zVAD-induced cell death, and 
knockdown of Atg 5, 6, or 7 markedly sensitized L929 cells to zVAD-induced death. 
This suggests that autophagy helps a cell to survive and that inhibition of lysosomal 
function in autophagolysosomes promotes zVAD-induced necrotic cell death (113). 
These observations are potentially important in developing novel therapeutic strategies 
for several diseases that involve the modulation of autophagy (51).  In cancer treatment, 
drugs inducing autophagy become more widely used in clinical practice. Treatment of 
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MCF7 breast carcinoma cells with tamoxifen, an estrogen receptor blocker, leads to 
autophagic cell death rather than apoptosis.  Although the underlying mechanism is still 
not clear, it is speculated that tamoxifen-induced autophagy leads to cell death due to its 
failure to restore normal function to cells (9).    
Cross talking between autophagy and apoptosis  
  Several lines of evidence have indicated that autophagy acts as a decision marker 
when apoptosis is crippled.  In MCF-10A cells expressing anti-apoptotic proteins, 
apoptosis induction via TRAIL stimulated autophagic cell death (69). This result implies 
that regulations of autophagy and apoptosis must be coordinated. In addition, the proteins 
shared in the central component of apoptosis and autophagy machinery such as Bcl-2 
family proteins and FADD also involve both processes (81).  Beclin 1/Atg6, an 
autophagy protein playing a role during autophagosome formation, has been considered 
as a connector between autophagy and apoptosis.  Bcl-2 family proteins are the major 
target of Beclin1 to inhibit apoptosis. The interaction between Bcl-2 and Beclin 1 results 
in failure of binding between Bcl-2 and Bax, resulting ininhibition of the release of 
cytochrome C that directly activates caspases and eventually leads to cell death via 
intrinsic apoptosis (27). Consistently, Kromer and his group also showed that the 
disruption of interaction between Beclin 1 and Bcl-2 protein family can enhance 
autophagy. It has been suggested that Bcl-2 as an anti-apoptotic protein also regulates 
autophagy as well (63). Although the underlying mechanism remains unclear, a study 
showed that Bcl-2 can block the release of calcium from the ER, which inhibits mTOR 
and activates autophagy (35). Not only does intrinsic apoptotic pathway involve in 
autophagy modulation, but extrinsic apoptosis pathway can serve as a key player as well. 
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Autophagy can be easily observed when apoptosis is blocked, indicating that autophagy 
and apoptosis are able to be induced through FADD (102). The study indicates that 
component of apoptosis machinery regulating both extrinsic and intrinsic pathways can 
also modulate autophagy.       
The balance in dual roles of autophagy  
  Autophagy regulates two opposite fates; cell survival and death, by either its pro-
survival or pro-death role. During nutrient depletion, autophagy suppresses apoptosis and 
promotes cell survival. On the other hand, Autophagy also functions as a type 2 
programmed cell death when cell survival cannot be maintained. In the fly, steroid 
controls the transcription regulator BR-C, E74A, and E93 to trigger autophagic cell death 
in D. melanogaster salivary glands (57).  Inhibition of caspases and external apoptotic 
stimuli can also induce autophagic cell death (69). Although it is not well understood 
how autophagy makes its decision between cytoprotective and cytotoxic outcome, it is 
strongly suggested that the balance in input from signaling pathways drive cells to either 
survive or die.  Perhaps some underlying mechanisms are essential to switch on when 
autophagy undergoes beyond the point of no return and commits cells to death. The 
connection between the dual roles of autophagy on cell survival and death requires better 
understanding.  
Autophagy and herpesviral infections 
 The best-characterized evidence of autophagy in host-pathogen interactions was 
described in engulfment of Mycobacterium tuberculosis in phagosomes and the trapping 
of cytosolic group A streptococci in autophagosomes. It implies that autophagy is a 
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protective mechanism against infection through destroying the pathogens in autolysomes 
that contain several enzymes such as acid hydrolase and lysozyme (18). Whereas facing a 
number of host defense mechanisms, pathogenic organisms employ various strategies to 
evade host defenses. In HSV-1, the ICP34.5, a neurovirulent protein interfering with PKR 
antiviral activity, can inhibit autophagy (18). This results in the preventing of the 
degradation of viral particles. Besides immune evasion, viruses also employ autophagy in 
different ways in order to gain advantages from host cells. Several studies indicate 
viruses replicate by evading or subverting the autophagy pathway. Interestingly, KSHV 
employs replication and transcription activator (RTA), an important viral protein for lytic 
reactivation, to enhance autophagosome formation and autophagosome fusion. The 
underlying mechanisms and reasons for enhancing autophagy remain unclear. However, 
it has been shown that RTA can induce protein degradation by ubiquitination pathway, 
which might be consistent with the function of autophagy on protein turnover process 
(109). Another KSHV protein that has been well studied is KSHV vFLIP, a protein 
expressed during latent infection. A number of previous studies have shown that this 
protein plays arole in inhibiting apoptosis and promoting cell transformation. KSHV 
vFLIP is involved in suppression of autophagosome formation by interacting with LC3 
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3.1 Cells and viruses 
Cell lines HeLa and HEK293 were maintained in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Transfection of the 
cells was done with GeneExpresso 8000 (Lab Supply Mall, Gaithersburg, MD) as per the 
manufacturer’s instructions. Cell line RhF was a gift from B. Damania (21) and 
maintained in DMEM supplemented with 10% FBS. RRV 26-95 was a gift from R.C. 
Desrosiers (7) and propagated in RhF cells. BJAB was maintained in RPMI1640 medium 
supplemented with 10% FBS. Stable HeLa cells expressing CFP-LC3 has been described 
previously (83) and maintained with DMEM supplemented with 10% FBS and G418 
(Invitrogen, Carlsbad, CA) at 400 µg/ml.  
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Establishment of RRV vFLIP-expressing stable HeLa cell line 
  We generated HeLa cells stably expressing RRV vFLIP fusing with yellow 
fluorescence protein (YFP). Briefly, HeLa cells were transfected with VenusN1-vFLIP 
and the cells containing the plasmid were selected in medium supplemented with G418 
(Invitrogen) at 400 µg/ml. Fluorescence-activated cell sorting was conducted to enrich 
cells with YFP expression. Sorted cells were plated and cultured to expand cell 
population. The sorting and expanding process was repeated three times to enrich and 
stabilize the cells with YFP expression. The vFLIP expression was confirmed with 
Western blotting analysis using rabbit anti-vFLIP antibody. The stable HeLa cells were 
stored in a liquid nitrogen container and used in this study. 
3.2 Apoptosis and autophagy induction 
Apoptosis induction 
Tumor necrosis factor-α (TNF-α) (R&D Systems, Minneapolis, MN) and 
cycloheximide (Sigma) were added to cells at final concentrations of 50 ng/ml and 2.5 
µg/ml, respectively, to induce apoptosis. The cells were harvested at different time points 
after apoptosis induction for RNA isolation or Western blotting analysis, as indicated. 
Either TNF-α or cycloheximide alone at their respective concentrations used in this study 
cannot induce apoptosis. To inhibit the autophagosome formation step in autophagy, cells 
were treated with 3-MA (Fisher) at a final concentration of 10 mM for one hour before 
apoptosis induction. To interrupt degradation of autophagosomes in lysosomes, cells 
were treated with ammonium chloride (Fisher) at a final concentration of 20 mM at 4, 6, 
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and 8 h after apoptosis induction. At 10 h after apoptosis induction, the cells were 
harvested for Western blotanalysis. 
Autophagy induction 
Rapamycin (R&D Systems) was added to confluent monolayer HeLa-LC3 stable 
cells at 4 µM final concentration to induce autophagy. The cells were fixed with 1% 
paraformaldehyde for confocal fluorescence microscopy at 6 and 9 h after the drug 
treatment or harvested for Western blot analysis, as indicated.  
3.3 Antibodies 
Preparation and purification of antibody against RRV vFLIP  
RRV vFLIP was expressed in BL21 E. coli cells as a fusion protein of vFLIP-
GST from pGEX-3X-vFLIP plasmid with the induction of 1 mM IPTG (Promega, 
Madison, WI). The vFLIP-GST fusion protein was purified by B-PER GST Fusion 
Protein Purification Kits (Fisher Scientific, Pittsburgh, PA) according to the 
manufacturer’s instructions. Purified vFLIP-GST fusion protein was used to immunize 
rabbits for vFLIP antibody preparation (GenScript Corporation, Piscataway, NJ). Rabbit 
anti-vFLIP antibody was purified from the antiserum by affinity-purification with 
CarboxyLink
TM 
Kit (Fischer Scientific), which was used to covalently link purified 
vFLIP-GST fusion protein to agarose beads. The vFLIP antibody was verified by 






The antibodies used to detect the level of cellular proteins in this study are against 
PARP-1, caspase-8, caspase-9, and NF-κB p65 (Santacruz biotechnology, Santa Cruz, 
CA); LC3 (Cell signaling); β-tubulin, GFP, and GST (Sigma) 
3.4 Plasmids and vectors 
The plasmid Venus-N1 and VenusC1 vectors that contain an improved version of 
yellow fluorescent protein named “Venus”. The N1 and C1 nomenclature of the Venus 
vector indicates the location of the mutli-cloning sites upstream and downstream of the 
Venus gene, respectively. The PGEX-3X vector (GE Healthcare) was used for expression 
of RRV vFLIP-GST fusion protein in BL21. The plasmid pGL4.32 [NF-КB-RE/Hygro], 
purchased from Progmega®, was used in NF-κB reporter assay.  
Construction of vetctor expressing RRV vFLIP  
Supernatant of RRV-infected RhF cells containing RRV DNA was used as template 
to amplify RRV ORF71 gene. PCR products were generated with primers R71F2 and 
R71R3 (Table 1), which contain restriction sites of EcoRI and BamHI, respectively, for 
directional cloning into VenusN1 vector, as previously described (42).  In addition, PCR 
products amplified from primers R71F2 and R71R2 (Table 1) were cloned into VenusC1 
vector. All clones were confirmed by restriction enzyme digestion and DNA sequencing. 
ORF71 was cloned upstream and downstream of Venus in VenusN1 and VenusC1, 
respectively. The expression of fusion proteins of vFLIP and Venus were easily observed 
under fluorescence microscope. As for protein expression in prokaryotic system, ORF71 
gene was amplified with primer R71F1 and R71R1 (Table 1) that contain restriction site 
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of BamHI and EcoRI, respectively, and cloned into pGEX-3X vector.  Furthermore, 
ORF71 gene was also cloned into pCMVTag2C and pCDNA3 vector. All clones were 
confirmed by DNA sequencing.  To study the function of truncated proteins of RRV 
vFLIP, fragments of ORF71 was cloned into VenusN1 vector to generate four plasmids 
with different primers (Table 1). All clones were verified for the presence of inserts by 
DNA sequencing. Construction of CFP-LC3 plasmid has been recently reported (65). 
Construction of mCherry-LC3 plasmid has been previously described (83). 
Table 1. Oligonucleotide used in generation of plasmids for expression of RRV vFLIP, 
truncated vFLIP proteins, and siRNA against vFLIP mRNA 
a. F, forward; R, reverse. 
b. Restriction sites of BamHI, XhoI and EcoRI included in the primers are italicized 
Primera Sequence (5’ to 3’)b Plasmid  
R71F1 GCGGATCCTGTTCCCGCATAAGCGGTT pGEX-3X 
R71R1 GAGAATTCTTAACCGGGTGCGTTGGCG  
R71F2 GCGAATTCCATGTTCCCGCATAAGCGGTT VenusC1-R71 
R71R2 GAGGATCCTTAACCGGGTGCGTTGGCGG  
R71F2 GCGAATTCCATGTTCCCGCATAAGCGGTT VenusN1-R71 
R71R3 GAGGATCCGAACCGGGTGCGTTGGCGGC  
R71F8 GGGCTCGAGATGTTCCCGCATAAGCG VenusN1-R71D1 
R71R7 CCGAATTCGAATGGAGAGCATCAGGTG  
R71F8 GGGCTCGAGATGTTCCCGCATAAGCG VenusN1-R71D2 
R71R8 GCGAATTCGCAGGTCACTTAAAACCATG  
R71F10 GCGCTCGAGATGTACAAACACCTGATGC VenusN1-R71D3 




Figure 2. Construction of RRV ORF71 expression plasmids. The ORF71 of RRV was 
cloned into VenusN1 vector, upstream of the Venus reporter gene (N1-R71) using the 
indicated restriction enzymes. In addition, ORF71 was also cloned into pGEX-3X vector 
to generate purified protein for antibody production.  
 
Figure 3. Schematic Illustration of the truncations of ORF71. Three vFLIP fragments 
were designed and cloned into VenusN1 vector, designated as D1, D2, and D3, 
respectively. Numbers above lines indicate nucleic acid bases of vFLIP open reading 
frame. FL: full length. 
3.5 Transfection        
Transient transfection was conducted on HEK293 and HeLa cells grown to 90-95% 
and 65-70% confluence, respectively in 12-well plates. As for 293 cells, 8 μl 
polyethylenimine (polysciences) was mixed with 2 μg of plasmid or empty vector DNA 
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in a volume of 100 μl of DMEM-RS (Hyclone) per well. For transfection of HeLa and 
RhF cells, 2 μg plasmid DNA was mixed with LF2000 (Invitrgoen), according to the 
manufacturer’s instructions. Cells treated with only the transfection reagent were served 
as mock-transfection controls.  Cells were harvested at 18 to 24 h after transfection for 
protein expression unless indicated in text at different time points. 
3.6 Confocal fluorescence microscopy 
Cells were seeded directly onto cell culture plates containing coverglass, incubated 
overnight, and transfected the next day. At 24 h post transfection, the coverglass was 
observed directly under confocal fluorescence microscopy or fixed with 1% 
paraformaldehyde and mounted onto slide with anti-fade mounting solution (Invitrogen) 
before observation.  
3.7 Western blot analysis 
Cells were transfected with either VenusN1-vFLIP or VenusN1 vector. At 24 h post-
trasnfection, the cells were harvested with Laemmli sample buffer.  The whole proteins in 
cell lysates were separated onto 12% polyacrylamide gel. The proteins were transferred 
to nitrocellulose membrane and probed with rabbit anti-vFLIP antibody. Specific signal 
through the reaction of horseradish peroxidase isoenzyme with hydrogenperoxide and 
chemiluminescence substrate were detected by using ChemiDoc XRS imaging system 
(Bio-Rad Laboratories, Hercules, CA).  Beta-tubulin was detected on the same blot 
membrane to normalize protein loading. Digital image acquisition and densitometry 
analyses were conducted using Quantity One program (Version 4.6) (Bio-Rad). Likewise 
in other experiments, the expression of other proteins was detected with antibodies as 
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follows; GST (Rockland Immunchemicals Inc., Gilbertsville, PA), GFP, -tubulin 
(Sigma), LC3 (Cell Signaling Technology, Danvers, MA), NF-B p65, PARP-1, and 
caspase-9 (Santa Cruz Biotechnology, Santa Cruz, CA). 
3.8 Cell viability assay  
Cells viability was determined with CellTiter-Glo Luminescent Cell Viability Assay 
(Promega). The ATP level in cells associates with the number of viable cells in culture. 
This method was conducted to measure the amount of ATP in cells before and after 
apoptosis induction and nutrient starvation. As for apoptosis experiment, cells cultured in 
96-well plate were induced to undergo apoptosis for 4 h prior to addition of Cell titer-Glo 
reagent and incubated for 10 minutes at room temperature. For nutrient starvation, the 
cells were seeded into a 12-well culture plate and incubated overnight at 37C. On next 
day, the culture medium was then replaced with Hank’s Balanced Salt Solution (HBSS). 
The cells were observed under a microscope before harvesting at 0, 24, and 48 h after the 
addition of HBSS. The luminescence signal generated from luciferase reaction was 
measured with a VICTOR
3
 Multilabel Counter (Perkin-Elmer, Waltham, MA). Relative 
percentages of luminescence intensity were analyzed by comparison to mock-treated 
controls.  
3.9 Caspase activity assay  
Activities of caspase-3, -7, -8, and -9 were measured by using Caspase-Glo 3/7, 
Caspase-Glo 8, and Capase-Glo 9 Assay kits (Promega). Cells seeded onto a 96-well 
culture plate were induced to undergo apoptosis for 4 h prior to testing of caspase 
activities. Caspase-Glo reagent was added to the cells and incubated for 30 minutes at 
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room temperature. The luminescence signal was measured and converted to the relative 
percentages of luminescence intensity, which was compared with controls.  
3.10 NF-B reporter assay 
HeLa cells were co-transfected with pGL43.2 [luc2p/ NF-B/Hygro] Vector 
(Promega) that contains a NF-B responsive element driving transcription of luciferase 
reporter gene and either VenusN1-vFLIP or VenusN1 empty vector. VenusC1-vFLIP and 
VenusC1 plasmids were also included in this assay. Plasmid pRL-TK (Promega) was 
used as an internal control for all transfection. As for positive control, cells were induced 
with TNF-α (at concentration of 50 ng/ml) in order to activate the transcolation of NF-
B. For negative control, a prokaryotic vector pGEX-3X was used to co-transfect with 
NF-B reporter vector.  Dual-Glo Luciferase Assay System (Promega) was used to detect 
luciferase activity at 4 h after TNF-α addition following the manufactuer’s instructions. 
The change in the activity of lucicerasewas determined by comparing the normalized 
luciferase activity in treated versus untreated transfectants in terms of relative folds.  
3.11 Subcellular fractionation 
Nuclear fraction was extracted from normal HeLa and HeLa-VFLIP stable cells using 
the CelLytic NuCLEAR Extractino Kit (Sigma). Cell were collected, lysed, and 
fractionated by following manufacturer’s instructions. The nuclear and cytoplasmic 
fractions were subjected to Western blot analysis. Antibodies against cytoplasmic protein 
(β-tubulin) and nuclear protein (PARP-1) were utilized to assess the success of 
subcellular fractionation.  
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3.12 Design and testing of siRNA 
siRNA Target Designer (version 1.6) was used to design siRNA against ORF71 
mRNA, according to manufactuer’s instruction (Promega). Short duplex DNA 
oligonucleotides containing T7 polymerase promoter upstream of either the sense or 
antisense DNA sequences of siRNA against ORF71 of RRV were used as a template to 
generate siRNA using T7 RiboMAX
TM
 Express RNAi system (Promega). Briefly, 
oligonucleotides were annealed to generate either sense or antisense RNA template. Two 
separated RNA templates were assembled for each siRNA after transcription. The 
silencing effect of siRNA against ORF71 was tested by co-transfection with Venus-N1-
vFLIP in 293T cells. Cells with Venus expression were observed under fluorescence 
microscope. The mRNA level of ORF71 was also determined in RRV-infected BJAB 
cells by Real-time PCR.  
3.13 Real-time PCR 
Total RNA was isolated from cell lysed with TRIzol® Reagent (Invitrogen). RNA 
was treated with RNase free –DNAse (Promega) to remove carryover DNA from RNA 
isolation procedure. RNA transcription was conducted using AMV reverse transcriptase 
and random hexamer (Promega). Real-time PCR primers designed based on cDNA 
sequences of target mRNA are shown in Table 2. Real-time PCR with SYBR Green 
detection was done as described previously (78). The gene expression level in vFLIP-
expressing cells was quantified by 2-
ΔΔCT
 method in comparison with a control of cells 




Table 2. Oligonucleotides used in real-time PCR 























CHAPTER 4: RESULTS 
4.1 Cloning and expression of RRV ORF71 gene 
RRV ORF71 was cloned into pGEX3X vector for expression of vFLIP-GST 
fusion protein. The expression of the protein was detected with mouse anti-GST 
antibody. The fusion protein was purified and used to immunize rabbits for antibody 
preparation. The rabbit antibody against vFLIP was purified by affinity chromatography 
and confirmed for its specificity in Western blot analysis with vFLIP-GST protein.  
The expression of vFLIP fusion protein occurs both in the cytoplasm and nucleus 
in a diffuse or homogenous pattern, when observed under confocal microscopy.  In RhF 
cells transfected with VenusN1-vFLIP, vFLIP fusion protein mainly localizes in the 
nucleus, while a similar cellular distribution pattern was clearly observed in HeLa cells 
(Fig 4). The result observed in RhF cells was consistent with the previous studies of 
vFLIP of KSHV. HEK293 cells were transfected with VenusN1-vFLIP or empty vector. 
The vFLIP-Venus fusion protein was detected by a mouse monoclonal antibody against 
GFP and the size of the fusion protein was approximately 45 kDa, while cells transfected 
with the empty vector yielded a band at 25 kDa as expected (Fig 5A). Western blot 
analysis of the cell lysates with the rabbit anti-vFLIP antibody detected the 45 kDa fusion 
protein, while no signal was visible in whole proteins from cells transfected with empty 
vector demonstrating the specificity of the antibody against vFLIP (Fig 5B). These results 
confirmed the expression of vFLIP fusion protein in transiently transfected cells. Our 
attempt to express vFLIP in other vectors with FLAG tag or without Tag, such as pCMV-
Tag and pCDNA3, was unsuccessful. Expression of vFLIP from such plasmids was 
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below detection level in transiently transfected cells by IFA or Western blot. However, 
the expression of RRV vFLIP from pcDNA3-vFLIP was clearly detected when a cell-free 
transcription and translation system was used.  This indicates that the vFLIP protein was 
very unstable or short-lived and the fusion with Venus enhances the stability of vFLIP.  
                      
Figure 4.  Subcellular localization of RRV vFLIP fusion with YFP. The cells were 
transfected with VenusN1-vFLIP or empty vector (EV).  A. HeLa cell transfected with 
empty vector. B. HeLa cell transfected with VenusN1-vFLIP. C. RhF cells tranfected 
with empty vector.  D. RhF cells tranfected with VenusN1-vFLIP.  




                                                                     
Figure 5. Detection of RRV vFLIP protein by Western blotting analysis.  The cells 
were transfected with VenusN1-vFLIP or empty vector (EV).  A. Detection of vFLIP-
Venus fusion protein by mouse anti-GFP antibody. B. Detection of vFLIP-Venus fusion 
protein by rabbit anti-vFLIP antibody.  Molecular weight markers are indicated on left of 
the images.  
4.2 RRV vFLIP inhibits apoptosis  
  Since two death effector domains have been shown anti-apoptotic function in 
sereral vFLIPs, we tested RRV vFLIP effect on apoptosis pathway. HeLa and HeLa-
vFLIP stable cells were induced to undergo apoptosis with TNF- and cycloheximide, 
and harvested at 0, 6, 9, and 12 h after the treatment. Cleavage of PARP-1 was assessed. 
PARP-1 is a nuclear DNA-binding zinc finger protein that influences DNA repair and 
apoptosis. PARP-1 proteolytic cleavage is considered as a classical hallmark for 
apoptosis. The strong PARP-1 cleavage bands at 89 kDa were clearly observed in control 
HeLa cells at 6, 9 and 12 h after apoptosis induction, while not detectable in the cells 
expressing vFLIP The apoptosis induction leads to the cleavage of inactive pro-caspases 
to active caspases.  We detected pro-caspase 9 level in the cells and noticed that the level 
of pro-caspase 9 was serially decreased after 6 to 12 h in HeLa cells. However, vFLIP 
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expression did not lead to much change in precursor caspase 9 (Fig 6). The results 
indicate that vFLIP inhibits apoptosis.  
To further confirm the vFLIP effect on apoptosis signaling, we conducted caspase 
activity assays at 6 h after the apoptosis induction. Caspase activities of caspase 3/7, 8, 
and 9 in vFLIP-positive cells were 55%, 13% and 58% lower, respectively, than those in 
control HeLa cells(Fig 7). The caspase 9 and caspase 3/7, representing an initiation factor 
of intrinsic apoptosis pathway and executive factors, respectively, were effectively 
inhibited, although we did not observe much change of caspase-8 activity. The reduction 
of caspase activities of caspase-3, -7 and -9 in HeLa-vFLIP cells may account for the 
minimal cleavage of PARP-1.   
Reactive oxygen intermediates play a critical role in apoptosis induced by TNF-α 
and cycloheximide and overexpression of manganese superoxide dismutase (MnSOD) 
prevents apoptosis (32) . Superoxide dismutases (SOD) are a class of enzymes that 
catalyze the dismutation of superoxide into oxygen and hydrogen peroxide. Three forms 
of superoxide dismutase are present: SOD1 is located in the cytoplasm, SOD2 in the 
mitochondria, and SOD3 is extracellular. SOD2 has manganese in its reactive centre and 
is also known as MnSOD (66). The transcripts of several genes in apoptosis pathway 
including Bax, Bad, Bid, and MnSOD were assessed by real time RT-PCR at 4 h after 
apoptosis induction. Only MnSOD expression was highly up-regulated to almost 90 folds 
in HeLa-vFLIP stable cells as compared with control (Fig 8). The MnSOD elevation was 
consistent with the reduction of caspase-9 activity and unchanged procaspase-9 level in 
vFLIP-stable cells. Reactive oxygen species are directly involved in intrinsic apoptosis by 
increasing the threshold of mitochondria outer membrane permeability. This results in the 
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leakage of cytochrome C from mitochrondria which further activates the cleavage of 
active caspase-9.   
Our data above shows that RRV vFLIP inhibits signaling cascade of apoptosis 
pathway. To test whether the anti-apoptotic function of vFLIP is sufficient to protect the 
cells from apoptotic cell death, the HeLa-vFLIP stable cells were treated with TNF-α and 
cycloheximide to induce apoptosis. Cell viability assay was conducted at 0 and 38 h after 
the apoptosis induction. Compared with normal HeLa cells at 0 h, relative cell viability of 
HeLa-vFLIP stable cells at 38 h after apoptosis induction was 0.85-fold, while that of the 
control cells was 0.43-fold, similar to 0.39-fold of un-transfected HeLa cells. This result 
indicates that vFLIP expression can protect the cells against apoptosis (Fig 9).  
    
Figure 6. Detection of PARP-1 and Procaspase-9 by Western blot analysis. HeLa and 
HeLa-vFLIP stable cells were treated with tumor necrosis factor-α (TNF-α) and 
cycloheximide to induce apoptosis, and harvested at 0, 6, 9, and 12 h after the treatment. 
PARP-1 cleavage was detected as a marker of apoptosis. Cleavage of procaspase-9 
indicates activation of caspase 9, an initiator of apoptosis. Tubulin was detected on the 
same membrane for loading normalization.  
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Figure 7. Activity assay Caspase-3,-7,-8, and -9. HeLa-vFLIP stable cells and HeLa 
cells were treated with TNF-α and cycloheximide for 6 h. Relative percentages of caspase 
activities in comparison with normal HeLa cells are shown. Significant differences 
between HeLa-vFLIP and HeLa cells are denoted by “**”, which indicates P < 0.01.   
           
Figure 8. Detection of MnSOD transcript in HeLa-vFLIP stable cells after apoptotic 
induction. Real time PCR was conducted. Relative fold in comparison with normal 
HeLa cells under the same treatment is shown. 
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Figure 9. Cell viability assay of HeLa cells. HeLa-empty vector (EV) and HeLa-vFLIP 
cells at 0 and 38 h after apoptosis induction. Relative folds in comparison with normal 
HeLa cells at 0 h are shown. Significant differences between HeLa-vFLIP and HeLa-EV 
cells are denoted by “**”, which indicates P < 0.01. 
4.3 RRV vFLIP does not activate NF-κB pathway 
It is known that KSHV vFLIP strongly activates NF-κB signaling (11). Binding of 
KSHV vFLIP to IKK gamma induces phosphorylation and subsequent recognition by 
ubiquitinating enzyme system, which liberates NF-κB from association with inhibitory 
IKB proteins to nucleus. The nuclear translocation of NF-κB promotes transcription of a 
large number of genes involved in immune responses, inflammation, cell survival and 
cancer. To test whether RRV vFLIP has a similar role, we transfected HeLa cells with 
NF-κB reporter plasmid pGL4.32[LUC2P/NF-κB-RE/HYGRO] and VenusN1-vFLIP. 
VenusC1-vFLIP and empty vector were included in the test. TNF-α was included to 
activate NF-κB signaling as a positive control. The luciferase reporter assay showed that 
luminescence signals in cells with vFLIP expression was low and similar to cells 
transfected with empty vector, while TNF-α treatment of normal HeLa cells induced 12-
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fold increase. TNF-α treatment of HeLa cells transfected with VenusN1-vFLIP induced 
9-fold elevation (Fig 10). Transfection of HeLa cells with prokaryotic vector pGEX-3X 
did not affect the NF-κB activation after TNF-α induction. This result indicates that 
vFLIP is unable to activate NF-κB signaling.   
To verify the finding in NF-κB luciferase reporter assay, we conducted 
subcellular fractionation of HeLa cells to determine NF-κB subcellular location. After 
NF-κB is activated by TNF-α, it translocates into the nucleus and activates the expression 
of myriad genes. HeLa and HeLa-vFLIP stable cells were untreated or treated with TNF-
α. Addition of TNF-α and cycloheximide to one well was included as a control. The cells 
were harvested at 4 h after induction and fractions of nucleus and cytoplasm were 
separated. Western blot analysis with antibody against NF-κB p65 subunit showed that 
p65 remained in the cytoplasm ofthe cells with stable vFLIP expression, while addition of 
TNF-α or combination of TNF-α and cycloheximide led to p65 nuclear translocation 
(Fig. 11). This result suggests that vFLIP is unable to cause nuclear translocation of NF-
κB. Detection of β-tubulin in cytoplasmic fraction only and PARP-1 in nuclear fraction 
only demonstrated the successful separation of cytoplasmic and nuclear fractions. The 
unique feature of KSHV vFLIP in NF-κB activation has subsequent implications to 
pathogenesis of Kaposi’s sarcoma as well as malignant tumor caused by KSHV infection.  
The abolishment of NF-κB activation can reverse the protective effect of KSHV vFLIP 
against growth factor withdrawal-induced apoptosis. Although the underlying mechanism 
of NF- κB translocation mediated by KSHV vFLIP remains unclear, it was suggested that 
Bcl-XL is involved in this process. Upregulation of this protein due to NF-κB has been 
shown to inhibit the processing of caspase-9, -6, and -8. However, besides Bcl-XL, several 
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genes involved inapoptosis pathway are also upregulated including A1 cIAP, cIAP2, 
XIAP, and IEX-1. Strong evidence demonstrated that NF-κB activation mediated by 
KSHV vFLIP correlates with transforming ability. Rat-1 cells expressing KSHV vFLIP 
form colonies in soft agar, and nude mice injected with those cells developed tumor. 
These results suggest that NF-κB activation caused by KSHV vFLIP play an important 
role in the pathogenesis of KSHV associated malignancies by inhibiting apoptosis and 
promoting cell transformation.   
                           
Figure 10. NF-κB reporter assay. HeLa cells were transfected with NF-κB reporter 
plasmid pGL4.32[LUC2P/NF-κB-RE/HYGRO], VenusN1-vFLIP (vF1), VenusC1-vFLIP 
(vF2), empty vector VenusN1 (EV1), or VenusC1 (EV2).  TNF-α was used to activate 
NF-κB as a positive control. Prokaryotic expression vector pGEX-3X was included as a 
control. Luciferase signals were measured at 4 h after TNF-α addition. Relative folds in 
comparison with EV1 control are shown. There was no significant difference between 
vF1 and EV1 or between vF2 and EV2. Significant differences between cells with vF1 in 
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the presence or absence of TNF-α induction are denoted by “**”, which indicates P < 
0.01. 
                           
Figure 11. Subcellular fractionation to determine NF-κB nuclear translocation. 
HeLa cells (top panel image) and HeLa-vFLIP stable cells (lower panel image) were 
treated with TNF-α or combination of TNF-α and cycloheximide for 4 h and harvested 
for fractionation of cytoplasmic and nuclear portions, followed by Western blot analysis 
with p65 antibody. Tubulin and PARP-1 were detected on the same membrane to confirm 
the separation of cytoplasmic and nuclear fractions 
4.4 Enhanced cell survival under starved condition in cells expressing vFLIP   
Enhanced cell survival is one of the features of tumor cells. An increase of 
reactive oxygen species, depletion of nutrient, and waste product from rapid cell growth 
leads to hypoxic environment and nutritional stress to the cells, which interferes with cell 
survival. To determine whether RRV vFLIP can enhance cell survival under starved 
condition, we replaced cell culture medium of HeLa, HeLa-vFLIP, and HeLa-VenusN1 
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cells with HBSS. These cells were observed at 0, 24, and 48 h after HBSS addition and 
images were taken under bright field microscopy. HeLa-vFLIP stable cells survived 
longer than the other cells under starved condition, particularly at 48 h, the number of 
live vFLIP-stable cells were much more (Fig. 12A). Cell viability of vFLIP-stable cells 
was 1.24- and 1.58-fold higher than control HeLa cells at 24, and 48 h, respectively, after 
HBSS addition (Fig. 12B). The cells with empty vector had a slightly lower viability 
levels than control HeLa cells. This result indicated that RRV vFLIP might be involved 
in autophagy to extend cell survival as autophagy is a cell survival mechanism to turn 
over damaged organelles and long-lived proteins in the cytoplasm during starvation. It 
has been known that autophagy increases during starvation. This process allows cells to 
degrade long-lived protein and organelles so that they can obtain a source of 
macromolecular precursors such as amino acids, fatty acids, and nucleotides. Autophagy 
serves as a cell survival strategy to protect cells during nutrient deprivation. Strong 
evidence for the importance of autophagy in tumor cells was shown by an increase of 
autophagosome formation in the cells when deprived of growth/suvival factor. 
Knockdown of essential autophagic machinery component such as Beclin 1/Atg6 gene 
sensitized cells to starvation-induced death.  Furthermore, when autophagy was inhibited, 
those cells underwent apoptosis. This implies that autophagy that occurs under starved 
condition in tumor cells would prevent them from dying. Therefore, we would expect that 




                          
Figure 12. Effect of RRV vFLIP expression on HeLa cells under starved condition. 
A. Bright-field micrographs showing the cells under starvation at 0, 24 and 48 h. Normal 
HeLa, HeLa-vFLIP stable cells and HeLa-empty vector (EV) cells were starved after 
culture medium was replaced with Hank’s balanced salt solution (HBSS). B. Cell 
viability assay of HeLa cells after starvation. The cells were assayed at 24 and 48 h after 
starvation by CellTiter-Glo Cell Viability Assay. Relative folds are shown in comparison 
with normal HeLa cells at 24, and 48 h, respectively, after normalization of cells at 0 h. 
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Significant differences between HeLa-vFLIP and HeLa-EV cells are denoted by “*” and 
“**”, which indicate P <0.05 and P < 0.01, respectively. 
4.5 Elevation of autophagosome formation in cells with RRV vFLIP expressing after 
apoptosis induction 
 Autophagy is a dynamic and multi-step process and LC3-II has been widely used 
as a marker (65) . HeLa cells were co-transfected with VenusN1-vFLIP plasmid and 
mCherry-LC3 and, on next day, induced to undergo apoptosis with TNF-α and 
cycloheximide. The cells were observed for autophagosome formation after the apoptosis 
induction. The HeLa cells with vFLIP expression had more autophagosome punctates 
after apoptosis induction (Fig 13). The autophagosome punctates were more visible at 3 h 
after the apoptosis induction. The HeLa cells with vFLIP expression had more 
autophagosome punctates than control cells at both before and after apoptosis induction. 
For Western blot detection of LC3-II in the cells, HeLa and HeLa-vFLIP stable cells 
were transfected with CFP-LC3 plasmid and induced to undergo apoptosis the following 
day. The cells were harvested for western blot analyses at 0, 4, and 6 h after the apoptosis 
induction. The intensity of LC3-II band was used to assess autophagosome formation. A 
stronger LC3-II band was observed in HeLa-vFLIP stable cells than   HeLa cells at all 
time points tested (Fig 14). Autophagic vacuolization before apoptotic death has been 
demonstrated in several mammalian cells including HeLa, Bax-/Bak- DKO, and MEF 
cells(1). The kinetic studies indicated that autophagic vacuolization preceded 
mitochondrion-dependent caspase activation in apoptosis. It has been shown that 
inhibition of caspases had no influence on autophagic vacuolization and mitochondrial 
changes. Therefore, RRV vFLIP’s ability to reduce caspase activity might not be 
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responsible for an increase of autophagosome formation. The phenomenon of 
autophagosome formation drifts to a process marked by the conventional steps of 
apoptosis, which raise the question regarding the transitional phase between autophagy 
and apoptosis. In addition, autophagosome formation preceding apoptosis has been 
reported in Drosophila model system as well. 
To determine whether autophagy plays a role in vFLIP’s inhibition of apoptosis, 
we performed two experiments to inhibit autophagy at two critical steps; autophagosome 
formation and degradation of autophagosomes in lysosomes. HeLa-vFLIP stable cells 
were treated with 3-methyladenine (3-MA) for one hour before apoptotic induction to 
inhibit autophagosome formation. The cells were harvested at 10 h after apoptotic 
induction for Western blot analyses. The cleavage band of PARP-1 at 89 kDa was 
obviously observed in the cells treated with 3-MA, but not in mock-treated control (Fig 
15). This result indicates that after 3-MA treatment of the cells, vFLIP could no longer 
protect the cells from apoptosis, and suggests that autophagosome formation is needed 
for the anti-apoptotic function of RRV vFLIP, which is consistent with the observation of 
a significant increase of autophagosome punctates after apoptosis induction.  
We further tested whether final degradation of autophagic cargo inside 
autophagolysosomes had any effect on vFLIP’s inhibition of apoptosis. HeLa-vFLIP 
stable cells were treated with ammonium chloride at 4, 6, and 8 h after apoptosis 
induction to prevent pH drop in lysosomes and harvested for Western blot analysis. In 
HeLa-vFLIP stable cells, a cleavage band of PARP-1 at 89 kDa was observed at 4 and 6 
h, and became weaker at 8 h, while in HeLa cells with empty vector, a strong band of 
PARP-1 at 89 kDa was observed at all these time points (Fig. 16). This result indicates 
60 
 
that inhibition of autophagolysosomes at 4 and 6 h after apoptosis induction had a little 
effect on vLFIP’s anti-apoptotic function. An increase of autophagosome formation at an 
early time point in cells expressing vFLIP suggested an important role in apoptosis 
inhibition, while a later time point had less effect. In normal cells, the response of 
autophagic vacuolization at an early phase was much less observed and does not protect 
cells from apoptotic death. A similar phenomenon has been observed in other cell types 
including MCF-7 cells. MCF-7 cells treated with Camptothecin, a chemical inducing 
intrinsic apoptosis, rapidly underwent apoptosis, while simultaneously triggering an 
autophagic response in the cells can delay apoptotic death (9). Although the underlying 
mechanism regardingremains unclear how autophagic vacuolization participates in 
apoptosis inhibition, it has been hypothesized is that some proteins in apoptosis and 
autophagy have cross talk.  




Figure 13. Increased autophagosome formation in HeLa cells after apoptosis 
induction. RRV vFLIP expression leads to increase of autophagosome punctates in HeLa 
cells after apoptosis induction. HeLa cells were co-transfected with mCherry-LC3 and 
VenusN1-vFLIP or empty vector (EV), and on next day, induced with TNF-α and 
cycloheximide for 3 h. The cells were observed under confocal fluorescence microscopy. 
Nuclear DNA was counterstained with DAPI. Mock: no apoptosis induction. TNF: at 3 h 
after apoptosis induction. 
 
 
Figure 14. Upregulation of LC3-II in RRV vFLIP expressing cells after apoptosis 
induction by Western blot analysis. Increase of LC3-II in cells with vFLIP expression 
after apoptosis induction. HeLa-vFLIP stable and HeLa cells with EV were transfected 
with CFP-LC3, and, on the next day induced with TNF-α and cycloheximide to undergo 
apoptosis. The cells were harvested at 0, 4, and 6 h after the induction for Western blot 
analysis of LC3.  Tubulin was blotted for normalization. The relative ratios of LC3-II (the 
lower band of LC3 image) in comparison with HeLa-EV cells at 0 h after apoptosis 
induction are shown below the image. 
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Figure 15. Effect of 3-MA on anti-apoptotic function of RRV vFLIP. 3-MA was 
added to HeLa-vFLIP stable cells at 1 h before addition of TNF-α and cycloheximide. 
The cells were harvested at 10 h after TNF-α addition for Western blot analysis of PARP-
1 cleavage. 
 
                    
Figure16.  Effect of NH4Cl on anti-apoptotic function of RRV vFLIP.  NH4Cl was 
added to HeLa-vFLIP or HeLa-EV cells  at 4, 6 and 8 h after apoptosis induction. The 
cells were harvested at 10 h after TNF-α addition. 
4.6 Inhibition of autophagic cell death induced by rapamycin treatment 
The above data shows that RRV vFLIP protects cells against apoptosis by 
enhancing autophagosome formation. In addition to its undisputable role in cell survival 
in adverse conditions, autophagy can also be induced as a part of cell death that is 
described as type II programmed cell death (3). Autophagy literally is a defense 
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mechanism to enhance cell survival. We were interested in RRV vFLIP’s role in 
autophagic cell death. It was reported that cellular and viral FLIPs suppress autophagic 
cell death by preventing Atg3 from binding and processing LC3. To determine whether 
RRV vFLIP can also suppress autophagic cell death, we transfected HeLa-LC3 stable 
cells with VenusN1-vFLIP or empty vector and, on the next day, treated the cells with 
rapamycin, an mTOR inhibitor, at a final concentration of 4 µM. The cells were 
harvested for Western blott analysis and confocal microscopy at 0, 6, and 9 h after 
rapamycin treatment (Fig.17 and 18). A weaker band of LC3-II was observed in cells 
expressing vFLIP at 6 and 9 h after induction than cells with empty vector. The ratio of 
LC3-I:LC3-II was decreased from 1.46 at 0 h to 0.87 at 9 h in HeLa cells transfected with 
empty vector. With the presence of RRV vFLIP, the ratio of LC3-I:LC3-II was slightly 
increased from 1.26 at 0 h to 1.46 at 9 h. This result indicates that RRV vFLIP inhibits 




Figure 17. Autophagosome formation in HeLa cells after rapamycin treatment. 
Expression of vFLIP reduces autophagosome punctates induced by rapamycin. HeLa 
cells co-transfected with mCherry-LC3 and VenusN1-vFLIP or VenusN1 were treated 
with rapamycin for 6 h and observed under confocal fluorescence microscopy. Nuclear 
DNA was counterstained with DAPI. Before: at 0 h of rapamycin treatment. After: at 6 h 
after rapamycin treatment. 
 
Figure 18. Inhibition of rapamycin-induced autophagy in HeLa cells Reduction of 
LC3-II in RRV vFLIP expressing. vFLIP reduces LC3-II level induced by rapamycin. 
HeLa-LC3 stable cells were transfected with either VenusN1-vFLIP or empty vector, and 
on next day, treated with rapamycin. The cells were harvested at 0, 6, and 9 h after the 
treatment for Western blotting analysis with LC3 antibody. Tubulin was blotted for 
normalization. The relative ratios of LC3-II (the lower band of LC3 image) in 
comparison with HeLa-vFLIP stable cells at 0 h after rapamycin induction are shown 
below the image. 
4.7 Truncated vFLIP proteins lose the roles of the full-length vFLIP on apoptosis 
and autophagy pathway 
Our data above shows that RRV vFLIP inhibits apoptosis by enhancing 
autophagosome formation and suppresses autophagic cell death to promote cell survival. 
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To understand whether any specific vFLIP domains might be responsible for these 
effects, we generated RRV vFLIP deletion constructs and tested their roles in the 
inhibition of apoptosis and autophagic cell death. RRV ORF71 gene was used as a 
template to construct three truncation plasmids in VenusN1 vector. Western-blot analysis 
of whole proteins from cells transfected with these plasmids showed the expression of the 
three truncated vFLIP proteins (Fig. 19).  
HeLa cells transfected with the three vFLIP truncation constructs were treated 
with TNF-α and cycloheximide to induce apoptosis. The cleavage band of PARP-1 at 89 
kDa was obviously observed from cells transfected with each of the three truncated 
vFLIPs, similar to that from cells transfected with an empty vector or mock-transfected 
(Fig. 20). The cells transfected with plasmid of full-length vFLIP had no PARP-1 
cleavage after apoptotic induction. This result indicates that deletion at either amino- or 
carboxy-terminus of vFLIP disrupted its function in the inhibition of apoptosis.  
To test whether these truncations of vFLIP could inhibit autophagic cell death, we 
transfected HeLa-LC3 stable cells with individual deletion constructs and treated the cells 
with rapamycin. The cells were harvested at 6 h after the induction for Western blotting 
analysis. The intensity of LC3-II bands from cells transfected with the three vFLIP 
deletion constructs was similar to that from cells mock-transfected (Fig. 21). The LC3-
I:LC3-II ratio from all truncations and mock-transfected cells was much lower than that 
from cells with full length vFLIP and no-induction control. This result suggests that all 




Taken together, the full-length vFLIP protein is required to fulfill its function in 
the inhibition of apoptosis and autophagy. Possibly, the full-length protein might 
facilitate the proper protein folding, which allows RRV vFLIP to interact with cellular 
proteins.   
                    
Figure 19. Expression of the truncations of RRV vFLIP protein. Detection of 
expression of the vFLIP truncations in HEK293 cells by rabbit anti-vFLIP antibody. 
Molecular weight markers are indicated on the left of image. 
            
Figure 20. Truncation variants of RRV vFLIP protein are unable to inhibit 
apoptosis. . Full length vFLIP is needed for inhibition of apoptosis induced by TNF-α 
and cycloheximide. HeLa cells were transfected with VenusN1-D1, VenusN1-D2, 
VenusN1-D3, VenusN1-vFLIP (FL), and VenusN1 (EV). The cells were induced with 
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TNF-α and cycloheximide one  day post-transfection to undergo apoptosis, and harvested 
at 10 h after induction to detect PARP-1 cleavage. 
                  
Figure 21. Truncation variants of RRV vFLIP protein unable to inhibit rapamycin-
induced autohpagy. HeLa-LC3 cells were transfected with D1, D2, D3, and VenusN1-
vFLIP (FL). The cells were treated with 4 µM rapamycin next day, and harvested at 6 h 
after the treatment. Tubulin was blotted for normalization. The relative ratios of LC3-II 
(the lower band of LC3 image) in comparison with D1 after rapamycin induction are 
shown below the image. 
4.8 RRV latent infection of BJAB cells protects the cells against apoptosis induction 
and suppression of vFLIP with siRNA abolishes the protection  
Although several cell lines can be infected with RRV, the main target cells of RRV latent 
infection in vivo are B cells (7). To examine autophagy in RRV-infected cells, we used 
BJAB cells as latent RRV infection occurred in the cells and vFLIP is a latent protein and 
could play a role during the latent phase of RRV infection. BJAB cells were infected with 
RRV at 2 MOI and maintained for two weeks in culture. BJAB cells latently infected 
with RRV (BJAB-RRV) and normal BJAB cells were induced to undergo apoptosis and 
harvested for Western blot analysis at 2 h after the treatment. The cleaved band of PARP-
1 at 89 kDa was strong in BJAB, but much weaker in BJAB-RRV (lane 2 in each image 
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of Fig 22). To test whether autophagy is needed for the inhibition of apoptosis in BJAB-
RRV, we treated the cells with 3-MA for 3 hours prior to apoptosis induction or 
ammonium chloride at the same time of apoptosis induction. PARP-1 cleavage was 
highly increased in BJAB-RRV when treated with either 3-MA or ammonium chloride 
(lane 3 and 4 in the second image of Fig.22). These treatments also increased PARP-1 
cleavage in normal BJAB cells (lane 3 and 4 in the first image of Fig. 22), as expected. 
This result indicates that the anti-apoptotic function coupled with autophagosome 
formation in RRV-infected BJAB cells corroborates with the data in HeLa cells stably 
expressing vFLIP. Live cell counting demonstrated that BJAB-RRV had much more live 
cells than BJAB cells at 6 h after apoptosis induction (Fig. 23), which is consistent with 
the levels of PARP-1 cleavage in the cells. 
 To further confirm that the inhibition of apoptosis via antophagy pathway in 
RRV-infected BJAB cells was due to vFLIP expression, we treated BJAB-RRV cells 
with a siRNA against vFLIP to knockdown vFLIP expression in the cells. A siRNA 
against ORF-K9 of KSHV was included as a control. To test the efficacy and specificity 
of siRNA against vFLIP, HEK293 cells were cotransfected with VenusN1-vFLIP and 
siRNA against RRV vFLIP or KSHV K9. On the following day, the transfected cells 
were observed under fluorescence microscope. Fluorescence signal was significantly 
decreased in the cells cotransfected with VenusN1-vFLIP and siRNA against vFLIP as 
compared with control (Fig 24).  Real-time RT-PCR showed that vFLIP mRNA in 
BJAB-RRV was reduced significantly after treatment with vFLIP siRNA, while K9 
siRNA had no effect (Fig 25). The cells were induced to undergo apoptosis one day after 
the siRNA transfection. Western blotting analysis showed that PARP-1 cleavage was 
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increased in BJAB-RRV after treatment with vFLIP siRNA in comparison with the 
control siRNA to K9 (Fig. 26), indicating that vFLIP is needed for the apoptosis 
inhibition. Treatment of normal BJAB cells with both siRNAs led to a slight increase in 
PARP-1 cleavage after apoptosis induction. This result suggests that vFLIP can inhibit 
apoptosis via autophagy pathway in RRV-infected cells.  
                      
Figure 22 Latent infection of BJAB cells by RRV assists cell survival.  RRV latent 
infection of BJAB cells protects the cells against apoptosis and inhibition of autophagy 
abolishes the protective effect.  BJAB cells latently infected with RRV (BJAB-RRV) 
were either untreated, treated with 3-MA for 3 hours prior to apoptosis induction by 
TNF-α and cycloheximide or treated with ammonium chloride at the same time of the 
apoptosis induction. The cells were harvested at 2 hours post-apoptosis induction for 
Western blot analysis of PARP-1 cleavage. Similar treatment of uninfected BJAB cells 





                                                
Figure 23. Cell viability assay of BJAB and BJAB-RRV cells after apoptosis 
induction. Relative folds in comparison with uninfected BJAB cells at 0 h are shown. 
Significant differences between BJAB and BJAB-RRV cells after apoptosis induction are 
denoted by “**”, which indicates P < 0.01. 
        
Figure 24 siRNA mediated suppression of vFLIP expression in HEK293 cells 
transiently transfected with VenusN1-vFLIP. The cells were transfected with 
VenusN1-vFLIP plasmid. Transfection of the cells with siRNA against vFLIP or K9 was 
done at the same time of plasmid transfection. Observation under fluorescence 
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microscopy was conducted one day post-tranfection. The siRNA against KSHV K9 was 
included as a negative control. 
                                                                                          
Figure 25 siRNA-mediated suppression vFLIP expression in RRV-infected BJAB 
cells. BJAB cells latently infected with RRV were transfected with a siRNA against 
vFLIP. A siRNA against KSHV K9 was included as a negative control. The cells were 
harvested at 24 h after the transfection. Real-time RT-PCR was conducted to assess 
vFLIP transcript level. Relative percentages in comparison with mock-treated control are 
shown. Significant differences between siRNA-treated and mock-treated BJAB-RRV 
cells are denoted by “**”, which indicates P < 0.01. 
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 Figure 26  Suppression of RRV vFLIP gene expression in BJAB-RRV cells leads to 
loss of the capability of anti-apoptosis function. BJAB cells latently infected with RRV 
were transfected with siRNA against vFLIP at 15 hours before apoptosis induction.  
siRNA against KSHV ORFK9 was included as a control. Treatment of uninfected BJAB 
cells was included as a control. The cells were harvested at 2 hours after treatment with 










Chapter 5: Discussion 
Several γ-herpesviruses contain vFLIP genes. However, not all of the vFLIPs 
have similar functions. In this study, we found RRV vFLIP has anti-apoptosis function, 
similar to KSHV vFLIP. However, unlike KSHV vFLIP, RRV vFLIP cannot activate 
NF-B as shown by the NF-B reporter assay and nuclear translocation experiment. NF-
B is a pluripotent transcription factor that plays important roles in several cellular 
signaling pathways including apoptosis, cell adhesion, proliferation, innate- and adaptive-
immune responses, inflammation, stress response, and tissue remodeling (79). The gene 
expression in these pathways is coherently coupled with other transcription factors and 
cellular signals as well. Thus, the anti-apoptosis function of RRV vFLIP is not due to NF-
B signaling. Instead, our data show that RRV vFLIP inhibit apoptosis via enhancement 
of autophagy to promote cell survival, while autophagic cell death was inhibited.  
We expressed Venus-vFLIP fusion protein in this study. We could not detect 
vFLIP when vFLIP is expressed alone or with short tag, which indicates that the protein 
is very unstable or the turnover rate is high in the cells. We tried MG132, a specific and 
potent proteosome inhibitor, to the cells after transfection with the vFLIP expression 
plasmids and did not detect any vFLIP either, indicating the protein was possibly not 
degraded by the ubiquitin pathway if it was due to rapid degradation. Similarly, in RRV-
infected RhF or BJAB cells, the protein is also below detection level. It appears that the 
fusion with Venus stabilizes the protein. In transiently transfected cells, the protein 
locates in the nucleus and cytoplasm. The presence of the protein in cytoplasm is 
consistent with its function of anti-apoptosis, however, its presence in the nucleus might 
be linked to unknown functions.  
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We used a combination of TNF-α and cycloheximide to induce apoptosis. Either 
one of them could not induce apoptosis at the concentration used in this study. The 
cycloheximide sensitizes the cells to undergo apoptosis induced by TNF-α. The cleavage 
of procaspase 9 indicates that the intrinsic pathway was activated by the apoptosis 
induction. The caspase activity assay result is consistent with this observation. We 
speculate that the activation of intrinsic pathway might be due the combination of the two 
compounds or detection time after the induction. The second point is less likely as we 
tested caspase activity in several time points after the induction and a similar trend was 
observed. Our finding of up-regulation of MnSOD in HeLa-vFLIP stable cells is 
consistent with the activation of intrinsic pathway. MnSOD contributes to suppression of 
apoptosis by reducing accumulation of intracellular superoxide to enhance cell survival 
(103). 
Whereas an increase of MnSOD after KSHV infection is linked to NF-B 
activation, we found up-regulated MnSOD gene expression in HeLa cells with vFLIP 
expression in the absence of NF-B activation. This finding suggests that NF-B 
pathway may not be the only factor that controls MnSOD expression, but other 
transcription factors could also be involved in the regulation of this gene as well. It was 
reported that p53 responds to physiological stress by stimulating redox-controlling genes 
to reduce ROS level. The increase of MnSOD transcript in HeLa cells with vFLIP 
expression suggests that RRV vFLIP might employ p53 or other transcription factors 
(38).  
Expression of vFLIP in HeLa cells enhanced cell survival under starved 
condition. HBSS was added to the cells after growth medium was removed. As nutrient 
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deprivation induces autophagy, extension of cell survival of HeLa-vFLIP cells indicates 
that vFLIP suppresses autophagy. Autophagy is a multi-step process beginning with the 
formation of autophagosome-cytoplasmic vesicles that have a double membrane and 
contain cytoplasmic cargo, fusion of autophagosomes with lysosomes to become 
autophagolysosomes, and degradation of contents in the autophagolysosomes. 
Enhancement of cell survival under starved condition in HeLa-vFLIP stable cells 
prompted us to determine autophagy before and after apoptosis induction. Interestingly, 
we found that autophagosome formation was increased in HeLa-vFLIP stable cells at 
early time points after apoptosis induction. When autophagy was inhibited at either early 
autophagosome formation by 3-MA or late autophagosome degradation step by 
ammonium chloride, vFLIP could no longer protect the cells against apoptosis. The 
addition of ammonium chloride at 8 h after apoptosis induction to inhibit autophagosome 
degradation step had less effect on the function of RRV vFLIP in inhibition of apoptosis 
than earlier time points. The apoptosis induction in HeLa cells is much more efficient in 
the presence of ammonium chloride.This result suggests that autophagy at early time 
points after apoptosis induction is essential for RRV vFLIP to protect the cells from 
apoptosis. Our findings are consistent with previous publications that explored both 
apoptosis and autophagy pathways. For example, two colon-cancer-derived cell lines, 
colon 26 and HT29 significantly underwent apoptosis after the combination treatment of 
3-MA to inhibit autophagy and 5-FU to induce apoptosis (62). Likewise, MCF-7, a breast 
cancer cell line, delayed apoptotic death following autophagy induction by nutrient 
starvation. Inhibition of the expression of Beclin 1 and Atg7 stimulates apoptosis in 
DNA-damaged MCF-7 cells (1).  
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Noticeably, LC3-II was present at a relatively higher level in cells with RRV 
vFLIP expression than control cells even without apoptosis induction. We speculate that 
RRV vFLIP induces a basal level of autophagy to promptly respond to stress signals in 
order to promote cell survival. The accumulation of autophagosomes in HeLa-vFLIP 
stable cells is possibly due to increased formation or slower turnover rate. The data in 
Fig. 13 indicates more autophagosome formation might account for the increased level. It 
has been reported that autophagy in MCF-7 cells due to nutrient starvation delays 
apoptotic death induced by camptothecin, a DNA-damaging compound (1). In addition, 
treatment with autophagy inhibitors increased mitochondrial depolarization and caspase-9 
activity, resulting in apoptosis. RRV vFLIP also employs autophagy during early time 
points after apoptosis induction to protect cells against apoptosis.  
Although autophagy is considered a mechanism to enhance cell survival in 
adverse conditions, it is also classified as type II programmed cell death due to 
accumulation of autophagosomes in the cytoplasm under pathological conditions. It was 
reported that FLIP inhibits autophagic cell death induced by rapamycin by preventing 
Atg3 from binding and processing LC3 (58). The function of RRV vFLIP in the 
inhibition of autopahgic cell death is consistent with other vFLIPs described in the 
previous report. The autophagosome accumulation in HeLa-vFLIP stable cells at 6 and 9 
h after rapamycin treatment was much lower than control cells. This indicates that 
autophagosome formation was inhibited, possibly by preventing Atg3 from binding LC3 
as other vFLIPs. The enhancement of autophagosomes in HeLa-vFLIP stable cells after 
apoptosis induction indicates that a different mechanism is activated because vFLIP 
binding Atg3 inhibits autophagy. How the RRV vFLIP activates other mechanisms while 
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avoiding the effect of interaction with Atg3 is not known. We hypothesize that RRV 
vFLIP activates autophagy through interaction with a cellular factor activated by 
apoptosis induction. The up-regulation of MnSOD in HeLa-vFLIP stable cells is 
consistent with this hypothesis.  
The RRV vFLIP deletion mutants were established to determine their functional 
domains in the inhibition of apoptosis and autophagy. All of the truncated proteins failed 
to perform the functions, which implies that full-length vFLIP protein is required for the 
inhibition. However, small peptides containing DED1 2 helix or DED2 4 helix of 
FLIP are able to bind with FLIP and Atg3 and effectively interfere with Atg3-FLIP 
interaction, which results in autophagic cell death. We did not observe the induction of 
autophagic cell death in cells expressing the truncated vFLIP in our study. As we could 
not detect the expression of RRV vFLIP alone we used fusion protein with GFP was used 
in our study. It would be possible that GFP might interfere with the function of the RRV 
vFLIP truncation fragments though the possibility is remote.  
Since B cells are targeted by natural infection of RRV, BJAB cells were latently 
infected with RRV to verify the observation in HeLa cells with vFLIP expression. It has 
been reported that RRV latently and persistently infected immortalized B-cell lines (7). 
The expression of the cluster of RRV latent genes during the latent phase was verified by 
real-time RT-PCR. However, RRV vFLIP protein in BJAB cells with RRV latent 
infection was below detection level, indicating its short half life. Interestingly, BJAB 
cells with RRV latent infection resisted apoptosis induction. Moreover, when autophagy 
was inhibited with 3-MA or ammonium chloride, the BJAB cells with RRV infection lost 
the ability to escape from apoptosis. Knockdown of vFLIP expression with siRNA leads 
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to loss of the anti-apoptosis effect in BJAB-RRV, which indicates that vFLIP is possibly 
the viral gene accounting for the anti-apoptosis function. The data in BJAB cells is 
consistent with the observation in HeLa cells. There are other genes in RRV such as 
vBcl-2, which inhibits autophagy and apoptosis. Our data indicates that these other genes 
might not involve in the protection of cells from apoptosis induction via autophagy 
pathway.  
The exact mechanisms for RRV vFLIP to enhance autophagosome formation 
during early apoptosis remain unclear. Autophagy pathway is thought to contribute in cell 
survival by cross talking with apoptosis pathway. Mitochondria membrane 
permeabilization and cytochrome C release are a critical step during apoptotic cell death. 
However, when the damage in mitochondria is below the threshold required for 
apoptosis, the damaged mitochondria will be sequestered in autophagosomes. The 
autophagic process provides a source of metabolic energy in the form of ATP from 
damaged organelles and long-lived proteins. The dual effects of RRV vFLIP to enhance 
autophagy in apoptosis induction and inhibit rapamycin-induced autophagic cell death 
provide a great benefit to promote cell survival and prevent cell death. Further study on 
interaction of RRV vFLIP with cellular factors is warranted and may yield informative 
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